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Abbreviations	  	  BBB	   blood	  brain	  barrier	  BDNF	   brain	  derived	  neurotrophic	  factor	  cAMP	   cyclic	  adenosine	  tri-­‐phosphat	  cDNA	   complementary	  DNA	  CNS	   central	  nervous	  system	  DAG	   diacylglycerol	  DNA	   deoxy-­‐ribonucleic	  acid	  ECM	   extracellular	  matrix	  ECS	   electroconvulsive	  seizures	  ECT	   electroconvulsive	  therapy	  FRL	   Flinders	  resistant	  line	  FSL	   Flinders	  sensitive	  line	  FST	   forced	  swim	  test	  5-­‐HT	   5-­‐hydroxytryptamin	  (serotonin)	  5-­‐HT	  R	   5-­‐hydroxytryptamine	  (serotonin)	  receptor	  IDO	   indoleamine-­‐2,3-­‐dioxygenase	  IL	   interleukin	  iNOS	   inducible	  nitric	  oxide	  synthase	  i.p.	   intraperitoneal	  IP3	   inositol-­‐3-­‐phoshat	  LPS	   lippolysaccharide	  MDD	   major	  depressive	  disorders	  MHC	   major	  histocompatibility	  complex	  MMP	   matrix-­‐metalloproteinase	  mRNA	   messenger	  RNA	  PAMP	   pathogen-­‐associated	  molecular	  pattern	  PNS	   peripheral	  nervous	  system	  RNA	   ribonucleic	  acid	  SEM	   standard	  error	  of	  the	  mean	  TIMP	   tissue	  inhibitor	  of	  matrix-­‐metalloproteinases	  TLR	   toll-­‐like	  receptor	  TNF	   tumor	  necrosis	  factor	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Introduction	  	  To	   distinguish	   between	   mental	   and	   physical	   health	   is	   a	   common	   legacy	   that	  already	   existed	   back	   in	   the	   16th	   century,	  when	   René	   Descartes	   (1596	   –	   1650)	  proposed	   a	   distinction	   between	   the	   brain	   and	   the	   mind.	   He	   believed	   that	   the	  brain,	  which	  was	  part	  of	  the	  body,	  controlled	  behaviour	  only	  to	  the	  extent	  that	  it	  resembled	   that	   of	   animals,	   whereas	   the	   mind,	   which	   was	   independent	   of	   the	  body,	  provided	  us	  with	  our	  inimitable	  human	  mental	  capabilities.	  	  	  Disorders	   of	   thought,	   behaviour	   or	   mood	   have	   for	   a	   very	   long	   time	   not	   been	  shown	   to	  have	  any	  biological	   explanation.	  One	  of	   the	   first	   successful	  biological	  treatments	  of	  an	  illness	  that	  was	  then	  believed	  to	  be	  a	  psychiatric	  disorder	  was	  the	  treatment	  of	  paralytic	  dementia,	  also	  known	  as	  general	  paralysis	  of	  the	  insane.	  The	   progressive	   course	   of	   the	   disease	   went	   from	   symptoms	   of	   mania	   and	  euphoria	  to	  seizures,	  cognitive	  deterioration	  and	  dementia,	  ultimately	  leading	  to	  paralysis	   and	   death,	   and	   affected	   10-­‐15%	   of	   all	   institutionalized	   psychiatric	  patients	  at	   the	  turn	  of	   the	  century.	   It	  was	   found	  to	  be	  caused	  by	  the	  bacterium	  
Treponema	   pallidum,	   also	   known	   as	   syphilis,	   and	   successfully	   treated	   by	   the	  antibiotic	   penicillin.	   The	   increasing	   knowledge	   about	   underlying	   biological	  mechanisms	   of	   mental	   illnesses,	   such	   as	   mood	   disorders,	   gives	   rise	   to	   better	  treatment	  and	  will	  help	  to	  relieve	  us	  from	  the	  burden	  they	  impose	  on	  our	  health,	  happiness	  and	  productivity.	  	  Our	  behaviour	  is	  dependent	  on	  brain	  activity,	  which	  is	  determined	  by	  the	  two	  factors	  heredity,	  which	  forms	  the	  basis	  for	  our	  mental	  functions,	  and	  environment,	  which	  determines	  how	  that	  basis	  is	  formed	  and	  used.	  Not	  even	  identical	  twins,	  which	  were	  provided	  with	  the	  exact	  same	  genetic	  background,	  think	  and	  behave	  similar,	  due	  to	  differences	  during	  embryonic	  and	  adult	  environment.	  At	  the	  same	  time,	  similar	  variations	  in	  genes	  can	  be	  linked	  to	  similar	  behaviour	  (P	  Suchankova	  et	  al.,	  2009;	  Petra	  Suchankova	  et	  al.,	  2011).	  Thus,	  developmental	  changes	  in	  the	  CNS	  can	  be	  caused	  by	  external	  factors,	  which,	  therefore,	  have	  the	  ability	  to	  alter	  structure	  and	  function	  of	  the	  brain	  and	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subsequently	  cause	  changes	  in	  our	  personality	  (E.	  Chen,	  G.	  E.	  Miller,	  Kobor,	  &	  Cole,	  2011).	  	  Affecting	   more	   than	   120	   million	   people	   worldwide,	   depression	   is	   among	   the	  leading	  causes	  of	  disability	  worldwide	  (Kessler	  et	  al.,	  2007),	  yet	   little	   is	  known	  about	  the	  neurobiology	  of	  mood	  disorders.	  The	  symptoms	  include	  a	  long-­‐lasting	  depressed	  mood,	  feeling	  of	  guilt,	  anxiety,	  and	  reoccurring	  thoughts	  of	  death	  and	  suicide	   (Nestler	   et	   al.,	   2002).	   Even	   though	   there	   are	   many	   different	  pharmacological	  treatments	  available,	  the	  cause	  for	  depression	  remains	  unclear	  and	  not	  all	  patients	  can	  be	  treated	  successfully.	  	  Accumulating	   evidence	   shows	   that	   inflammation	   plays	   a	   crucial	   role	   in	   the	  pathology	  of	  psychiatric	  disorders	  (Dowlati	  et	  al.,	  2010;	  Irwin,	  2008;	  Irwin	  &	  A.	  H.	  Miller,	  2007;	  Pollak	  &	  Yirmiya,	  2002;	  Raison,	  Lucile	  Capuron,	  &	  A.	  H.	  Miller,	  2006).	   Patients	   suffering	   from	   depression	   and	   suicide	   attempters	   show	   raised	  levels	   of	   pro-­‐inflammatory	   cytokines	   in	   serum.	   A	   favoured	   hypothesis	   for	   the	  role	  of	  the	  immune	  system	  in	  the	  pathophysiology	  of	  depression	  is	  that	  patients	  suffering	   from	   depression	   and	   anxiety	   are	   afflicted	   with	   mental	   stress	   that	   in	  turn	   causes	   the	   body´s	   immune	   system	   to	   induce	   an	   inflammatory	   reaction.	  Alternatively,	  a	  low-­‐grade	  chronic	  inflammation	  could	  lead	  to	  dysfunctions	  in	  the	  brain.	   A	   third	   explanation	   might	   be	   that	   psychiatric	   functions	   partly	   rely	   on	  genetic	   factors	   that	   are	   coupled	   to	   inflammation.	   It	   is	   of	   great	   importance	   to	  investigate	  these	  mechanisms.	  	  	  As	   it	   is	   difficult	   to	   study	   inflammation-­‐related	   proteins	   and	   their	   role	   in	  psychiatric	   diseases	   in	   the	   human	   brain,	   animal	   studies	   prove	   to	   be	   of	   great	  importance	  for	  exploring	  these	  questions.	  Since	  it	  is	  out	  of	  the	  question	  to	  simply	  ask	   an	   animal	   how	   it	   feels,	   it	   is	   impossible	   to	   model	   certain	   symptoms	   of	  depression,	  such	  as	  excessive	  feelings	  of	  guilt	  or	  recurrent	  thoughts	  of	  death	  or	  suicide,	   in	   laboratory	  animals.	  Therefore,	   attempts	  have	  been	  made	   to	  develop	  animal	  models	  of	  depression	  that	  focus	  on	  other	  symptoms	  of	  MDD.	  One	  model	  in	  which	  animals	  can	  be	   tested	   for	  sickness	  or	  depressive-­‐like	  behaviour	   is	   the	  forced	   swim	   test	   (FST),	   which	   was	   used	   in	   this	   thesis.	   The	   effect	   of	   LPS	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administration	  on	  cytokine	  expression	  both	  centrally	  and	  peripherally	  has	  been	  documented	  before	  (Terrence	  Deak,	  Bellamy,	  &	  D’Agostino,	  2003;	  M	  K	  Hansen	  et	  al.,	   2000),	   and	   it	   has	   been	   shown	   that	   this	   stimulation	   leads	   to	   sickness	   and	  depressive-­‐like	   behavior	   in	   rodents	   (DellaGioia	  &	  Hannestad,	   2010;	   Frenois	   et	  al.,	  2007)	  that	  can	  be	  assessed	  in	  the	  FST.	  	  About	   20	   years	   ago	   the	   brain	  was	   still	   seen	   as	   an	   immune-­‐privileged	   organ.	   It	  was	  believed	  that	  the	  blood	  brain	  barrier	  (BBB)	  restricts	  the	  entry	  of	  any	  type	  of	  immune	  cell	  into	  the	  central	  nervous	  system	  (CNS)	  and	  that	  antigen	  from	  within	  the	  CNS	  could	  not	   reach	   the	   thymus,	   since	   there	  was	  no	   lymphatic	  drainage	  of	  the	  brain.	  Furthermore,	  cells	  within	  the	  brain	  were	  not	  believed	  to	  express	  major	  histocompatibility	  complex	  (MHC)	  molecules	  and	  thus,	  no	  antigen	  presentation	  to	  T-­‐cells	  could	  take	  place,	  even	  if	  a	  leukocyte	  made	  it	  through	  the	  BBB	  into	  the	  brain.	   It	   has	   been	   shown,	   however,	   that	   there	   are	   exceptions	   to	   these	  presumptions.	   Under	   inflammatory	   conditions	   the	   properties	   of	   both	   the	   BBB	  and	  cells	  within	   the	  CNS	  change.	  The	  endothelial	   cells	   that	  are	  part	  of	   the	  BBB	  express	  receptors	  that	  make	  it	  possible	  for	  leukocytes	  to	  migrate	  into	  the	  brain	  and	  cells	  within	  the	  brain	  express	  MHC	  molecules.	  Furthermore,	  it	  was	  observed	  that	  lymphatic	  drainage	  could	  occur	  at	  specific	  sites	  of	  the	  CNS,	  so	  leukocytes	  can	  exit	  the	  CNS	  and	  migrate	  into	  lymphatic	  tissues.	  	  Components	   of	   the	   immune	   system	   that	   are	   harmful	   under	   pro-­‐inflammatory	  conditions	   can	   be	   crucial	   for	   a	   down-­‐regulation	   of	   the	   inflammatory	   response	  and	  for	  stimulation	  of	  repair	  and	  e.g.	  remyelination	  after	  stroke	  lesions	  or	  brain	  trauma.	   Leukocytes	   are	   a	   potent	   source	   for	   neurotrophic	   factors,	   which	   have	  anti-­‐inflammatory	   features	  and	  can	  stimulate	  regional	   tissue	  and	   limit	  damage.	  This	  points	  towards	  a	  contradictive	  role	  of	  inflammation	  in	  the	  brain,	  which	  can	  both	  be	  positive,	  e.g.	  for	  the	  elimination	  of	  pathogens,	  removal	  of	  damaged	  tissue	  in	   lesions	  and	  promotion	  of	   regeneration	  and	  repair,	   and	  negative,	   e.g.	   causing	  tissue	  edema	  and	  swelling,	  vascular	  damage,	  collateral	  damage	  of	  inflamed	  tissue	  and	  aberrant	  regeneration	  and	  scar	  formation	  which	  limits	  further	  regeneration	  in	  the	  lesion,	  and	  the	  maintenance	  of	  an	  equilibrium	  that	  promotes	  the	  positive	  aspects	  of	  immune	  actions	  within	  the	  CNS	  is	  crucial.	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  Accumulating	   evidence	   shows	   a	   strong	   correlation	   between	   the	   presence	   of	  inflammation	   and	   symptoms	   of	  MDD	   (Irwin,	   2008;	   Irwin	  &	  A.	   H.	  Miller,	   2007;	  Konsman,	  Parnet,	  &	  Dantzer,	  2002;	  B.	  E.	  Leonard	  &	  Ayemu	  Myint,	  2009;	  M	  Maes	  et	   al.,	   1997;	   Michael	   Maes,	   2008;	   Michael	   Maes	   et	   al.,	   2009;	   N.	   Müller	   &	  Ackenheil,	  1998;	  O’Brien,	  Scott,	  &	  Dinan,	  2004;	  Parnet,	  Kelley,	  Bluthé,	  &	  Dantzer,	  2002;	  Pollak	  &	  Yirmiya,	  2002;	  Raison	  et	  al.,	  2006;	  Simmons	  &	  Broderick,	  2005;	  Zhu	  et	  al.,	  2010)	  and	  the	  role	  inflammatory	  mediators	  in	  this	  context	  needs	  to	  be	  clarified	  in	  order	  to	  unravel	  the	  complexity	  of	  this	  disease.	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Background	  	  
Depression	  	  Major	  depressive	  disorder	  (MDD)	  is	  the	  most	  common	  mood	  disorder	  and	  the	  second	  cause	  of	  disability	  worldwide	  (Licinio	  &	  Wong,	  2011).	  The	  symptoms	  that	  describe	  MDD	  are	  depressed	  mood,	  anhedonia	  (diminished	  pleasure	  and	  interest),	  weight	  loss	  or	  weight	  gain,	  insomnia	  or	  hypersomnia,	  fatigue,	  feelings	  of	  worthlessness	  or	  guilt,	  diminished	  ability	  to	  concentrate	  or	  indecisiveness,	  recurrent	  thoughts	  of	  death	  and	  suicide	  (The	  Diagnostic	  and	  Statistical	  Manual	  of	  Mental	  Disorders,	  DSM-­‐IV-­‐TR,	  American	  Psychiatric	  Association).	  	  MDD	   has	   been	   associated	   with	   a	   decrease	   in	   the	   volume	   of	   the	   amygdala,	  hippocampus	   and	   frontal	   cortex	   (Ongür,	   Drevets,	   &	   Price,	   1998)	   and	  antidepressant	   treatment	  has	  been	  shown	  to	  reverse	   this	  phenomena	  (F.	  Chen,	  Madsen,	  Wegener,	  &	  Nyengaard,	  2009,	  2010;	   Jansson,	  Wennström,	   Johanson,	  &	  Tingström,	  2009;	  Jayatissa,	  Bisgaard,	  Tingström,	  Papp,	  &	  Wiborg,	  2006).	  	  	  The	   “monoamine	   hypothesis	   of	   depression”	   suggests	   an	   imbalance	   in	  monoamine	  neurotransmitters	  such	  as	  serotonin,	  dopamine	  and	  noradrenaline.	  Many	   effective	   antidepressants	   have	   the	   common	   effect	   of	   acutely	   enhancing	  monoamine	   function	   (Ressler	   &	   Nemeroff,	   2000).	   Serotonin,	   also	   called	   5-­‐
hydroxytryptamine	   (5-­‐HT),	   belongs	   to	   the	   monoamine	   family	   of	  neurotransmitters	   and	   is	   derived	   from	   the	   amino	   acid	   tryptophan.	   Serotonin-­‐containing	   neurons	   are	   clustered	   within	   the	   nine	   raphe	   nuclei,	   each	   of	   which	  projects	  to	  a	  different	  region	  of	  the	  brain	  (Pytliak,	  Vargová,	  Mechírová,	  &	  Felšöci,	  2011).	   Serotonin-­‐selective	   reuptake	   inhibitors	   (SSRIs)	   are	   widely	   used	   and	  effective	  antidepressants.	  However,	  their	  therapeutic	  effects	  develop	  slowly,	  and	  the	  mechanism	  of	  action	  that	  mediates	  antidepressant	  effects	   is	  not	  believed	  to	  be	  due	   to	   the	   immediate	   elevation	  of	   extracellular	   serotonin	  but	   rather	  due	   to	  structural	  or	  functional	  adaptations	  of	  the	  CNS	  to	  chronically	  elevated	  serotonin	  levels.	   Apart	   from	   the	   5-­‐HT	   3	   receptor	   family,	   which	   are	   ligand-­‐gated	   ion-­‐
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channels,	   all	   serotonin	   receptors	   are	   G-­‐protein	   coupled.	   The	   5-­‐HT	   R1	   family,	  including	   5-­‐HT	  R1B,	   is	   inhibitory,	   and	   causes	   a	   decrease	   in	   intracellular	   cAMP	  production.	  5-­‐HT	  1B	  receptors	  are	  present	   in	  many	  parts	  of	  the	  brain,	  with	  the	  highest	  concentrations	  in	  the	  basal	  ganglia	  and	  striatum,	  where	  they	  inhibit	  the	  release	  of	  serotonin,	  and	  the	  frontal	  cortex,	  where	  they	  are	  believed	  to	  inhibit	  the	  release	  of	  dopamine	  5-­‐HT	  R2	  family	  members	  are	  excitatory,	  and	  activation	  of	  5-­‐HT	  R2A	  e.g.	   leads	  to	  secretion	  of	  the	  neurotransmitter	  acetylcholine,	  which	  can	  act	   directly	   on	   nicotinic	   receptors	   on	   immune	   cells	   and,	   thus,	   exert	   anti-­‐inflammatory	   effects	   (Pavlov	  &	  Tracey,	   2005).	  Both	  5-­‐HT	  1B	  and	  2A	   receptors	  are	   believed	   to	   be	   involved	   in	   the	   modulation	   of	   anxiety,	   addiction,	   learning,	  memory	  and,	  for	  this	  thesis	  most	  importantly,	  mood	  (Pytliak	  et	  al.,	  2011).	  	  Even	  though	  many	  of	  the	  current	  treatments	  for	  depression	  have	  in	  common	  the	  increase	   of	   neurotransmission	   at	   central	   serotonergic	   or	   noradrenergic	  synapses,	   the	   monoamine	   hypothesis	   of	   mood	   disorders,	   which	   says	   that	  depression	   is	   a	   direct	   consequence	   of	   a	   deficit	   in	   these	   diffuse	   modulatory	  systems,	   is	   not	   sufficient	   to	   explain	   e.g.	  why	   the	   antidepressant	   effect	   of	   these	  drugs	  takes	  several	  weeks	  to	  develop.	  Another	  hypothesis	  argues	  for	  the	  role	  of	  the	   hypothalamic-­‐pituitary-­‐adrenal	   (HPA)	   axis	   in	   depression.	   The	   HPA	   axis	   is	  regulated	   positively	   by	   the	   amygdala	   and	   negatively	   by	   the	   hippocampus	   and	  regulates	  the	  secretion	  of	  cortisol	   from	  the	  adrenal	  gland	  in	  response	  to	  stress.	  Pro-­‐inflammatory	   cytokines	   also	   activate	   the	   HPA	   axis	   and	   might	   inhibit	   the	  hippocampal	  negative	  feedback	  regulation,	  thus	  contributing	  to	  the	  mechanisms	  proposed	   in	   the	   HPA	   axis	   hyperactivity	   hypothesis	   of	   depression	   (Miura	   et	   al.,	  2008).	  However,	  accumulating	  evidence	  that	  inflammatory	  reactions	  and	  neural-­‐immune	   interactions	   are	   involved	   in	   the	   pathogenesis	   of	   depression	   and	   that	  they	  may	  be	  the	  cause	  for	  serotonergic	  and	  adrenocortical	  dysregulations	  lead	  to	  the	  cytokine	  hypothesis	  of	  depression.	  The	  key	  findings	  have	  been	  elevated	  levels	  of	  pro-­‐inflammatory	  cytokines,	  such	  as	  IL-­‐1β	  and	  TNFα,	  and	  increased	  oxidative	  and	   nitrosative	   stress,	   which	   are	   induced	   by	   internal	   and	   external	   factors	  (Michael	  Maes	  et	  al.,	  2009)	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A	  consequence	  of	  inflammation	  in	  the	  CNS	  is	  the	  loss	  of	  neurons	  and	  astrocytes	  (Rajkowska	  et	  al.,	  1999).	  The	  reduction	  of	  astrocytes	  might	  be	  a	  result	  of	  higher	  levels	  of	  indoleamine-­‐2,3-­‐dioxygenase	  (IDO),	  which	  itself	  is	  induced	  by	  cytokines	  (O’Connor	  et	  al.,	  2009),	  which	  leads	  to	  higher	  concentrations	  of	  quinolinic	  acid.	  This	  cannot	  be	  adequately	  metabolized	  and	  is,	  therefore,	  toxic	  to	  astrocytes.	  This	  shows	   the	   complexity	   of	   effects	   mediated	   by	   an	   increased	   production	   of	   pro-­‐inflammatory	  cytokines	  and	  other	  inflammatory	  mediators	  such	  as	  nitric	  oxide,	  whose	  synthesis	  is	  amplified	  by	  elevated	  levels	  of	  iNOS.	  	  
The	  Immune	  system	  	  Our	  immune	  system	  consists	  of	  two	  components	  in	  which	  different	  cells	  and	  molecules	  work	  cooperatively	  to	  provide	  host	  defense	  and	  to	  restore	  homeostasis.	  These	  two	  components	  are	  innate	  and	  adaptive	  immunity.	  	  
The	  Innate	  immune	  response	  	  The	  first	  line	  of	  defense	  against	  infections	  is	  provided	  by	  the	  innate	  immune	  response,	  which	  consists	  of	  cellular	  and	  chemical	  barriers	  such	  as	  skin,	  mucosal	  epithelia	  and	  antimicrobial	  molecules,	  blood	  proteins	  like	  complement	  and	  cellular	  defense	  mediated	  through	  phagocytes	  (macrophages	  and	  neutrophils)	  and	  natural	  killer	  cells.	  Its	  specificity	  is	  against	  molecules	  shared	  by	  groups	  of	  related	  microbes	  and	  molecules	  produced	  by	  damaged	  host	  cells	  and	  its	  diversity	  is	  limited,	  as	  it	  is	  germline	  encoded	  and	  not	  able	  to	  “learn”.	  It	  is	  highly	  important	  for	  the	  organism,	  as	  it	  is	  the	  only	  immediate	  protection	  against	  pathogens	  and	  tissue	  injury	  before	  e.g.	  the	  adaptive	  immune	  response	  has	  time	  to	  develop.	  	  
The	  Adaptive	  immune	  response	  	  There	  are	  two	  types	  of	  adaptive	  immune	  responses,	  called	  humoral	  immunity	  and	  cell-­‐mediated	  immunity	  that	  differ	  in	  their	  components	  and	  eliminate	  different	  types	  of	  microbes.	  Humoral	  immunity	  is	  mediated	  by	  antibodies	  that	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are	  produced	  by	  B-­‐lymphocytes	  and	  is	  the	  principle	  defense	  mechanism	  against	  extracellular	  microbes	  and	  their	  toxins.	  The	  receptors	  on	  the	  antibodies	  have	  a	  very	  large	  diversity	  as	  they	  are	  produced	  by	  somatic	  recombination	  of	  gene	  segments.	  Furthermore,	  the	  adaptive	  immune	  response	  has	  a	  memory	  function,	  thus	  it	  is	  able	  to	  remember	  if	  it	  had	  been	  presented	  to	  a	  specific	  antigen	  before,	  and	  if	  so,	  can	  augment	  the	  reaction.	  Cell-­‐mediated	  immunity	  is	  mediated	  by	  T-­‐lymphocytes	  and	  targets	  intracellular	  microbes	  such	  as	  viruses	  and	  some	  bacteria	  that	  are	  inaccessible	  to	  circulating	  antibodies.	  	  
Inflammation	  	  Inflammation	  can	  be	  classified	  as	  either	  acute	  or	  chronic.	  Acute	  inflammation	  is	  the	   initial	   response	   of	   the	   body	   to	   harmful	   stimuli	   and	   is	   characterized	  by	   e.g.	  heat,	  vasodilation	  and	  edema.	  During	  acute	  inflammation,	  effector	  molecules	  and	  cells	  are	  recruited	  to	  the	  site	  of	  infection	  or	  tissue	  damage	  in	  order	  to	  eliminate	  the	   cause	   of	   the	   inflammatory	   reaction.	   Following	   detection	   of	   the	   harmful	  stimulus,	  an	  inflammatory	  cascade	  is	   initiated	  via	  the	  secretion	  of	   inducers	  and	  mediators	   including	   cytokines,	   chemokines,	   histamines	   etc.	   The	   dominant	   cell	  type	  that	  is	  recruited	  during	  acute	  inflammation	  is	  neutrophils.	  When	  activated,	  they	   start	   releasing	   toxic	   effector	   molecules	   that	   were	   stored	   in	   granules	   by	  endocytosis	   and	   thereby	   fight	   the	  pathogen.	  After	   elimination	  of	   the	  pathogen,	  further	  macrophages	  are	  recruited	  to	  remove	  cell	  debris	  and	  restore	  the	  tissue	  at	  the	   site	   of	   inflammation.	   For	   restoration	   to	   happen,	   an	   important	   switch	   in	  secretion	  from	  pro-­‐inflammatory	  mediators	  to	  anti-­‐inflammatory	  ones	  must	  take	  place.	   Instead	  of	  neutrophils,	  monocytes	  are	  then	  recruited	  to	  the	  tissue,	  which	  facilitate	  the	  removal	  of	  dead	  cells	  and	  initiate	  tissue	  remodeling.	  	  Prolonged	  inflammation,	  known	  as	  chronic	   inflammation,	   leads	  to	  a	  shift	   in	  the	  cells	  present	  at	  the	  site	  of	  inflammation	  from	  neutrophils	  to	  macrophages	  and	  T-­‐lymphocytes.	   This	   can	   happen	   when	   the	   acute	   inflammatory	   response	   wasn´t	  strong	  enough	  to	  eliminate	  the	  pathogen,	  when	  the	  persistent	  irritant	  is	  not	  large	  enough	  to	  elicit	  an	  acute	  inflammatory	  response	  or	  by	  autoimmune	  reactions	  (R.	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K.	  Kumar	  &	  Wales,	  2010).	  The	  symptoms	  are	  much	   less	  severe	  as	  during	  acute	  inflammation	  but	  can	  still	  cause	  harm.	  Macrophages	  present	  the	  antigen	  to	  T-­‐cells,	  which	  start	  secreting	  cytokines	  that	  in	  turn	  activate	  macrophages	  to	  produce	  chemokines,	  nitric	  oxide	  (NO),	  reactive	  oxygen	  species	  (ROS)	  and	  certain	  metalloproteinases.	  Thereby,	  the	  effector	  cells	  stimulate	   each	   other	   and	   the	   inflammatory	   response	   builds	   up,	   ultimately	  turning	   into	   a	   harmful	   situation	   for	   the	   host	  with	   tissue	   damage	   and	   cell	   loss.	  This	  detrimental	  cascade	  of	  chronic	  inflammation	  is	  suggested	  to	  be	  involved	  in	  diseases	  like	  cardiovascular	  diseases	  and	  cancer.	  	  Matrix	  metalloproteinases	  (MMPs)	  are	  proteolytic	  enzymes	  that	  are	  involved	  in	  the	   maintenance	   and	   remodeling	   of	   the	   extracellular	   matrix	   in	   a	   variety	   of	  physiological	   processes	   and	   pathological	   conditions,	   such	   as	   inflammation	   and	  cancer.	  Among	  the	  four	  identified	  TIMPs	  in	  vertebrates,	  TIMP-­‐1	  is	  the	  inducible	  form,	  which	  is	  sensitive	  to	  up-­‐regulation	  by	  e.g.	  IL-­‐1β	  and	  IL-­‐6.	  TIMP-­‐1	  binds	  to	  an	   active	   zinc-­‐binding	   site	   on	   MMPs	   with	   its	   N-­‐terminal	   domain	   and	   thereby	  mediates	  inhibition	  (Gomez,	  D.	  Alonso,	  Yoshiji,	  &	  Thorgeirsson,	  1997).	  MMPs	  and	  TIMPs	  play	  a	  central	  role	   in	  the	  structural	  plasticity	  of	  the	  brain,	  and	  a	  balance	  between	  them	  is	  crucial	   for	  maintaining	  physiological	  conditions.	  An	  imbalance	  between	   MMP	   and	   TIMP	   is	   implicated	   in	   the	   pathogenesis	   of	   CNS	   disorders	  involving	  inflammation	  (Gardner	  &	  Ghorpade,	  2003).	  A	  differential	  regulation	  of	  TIMP-­‐1	   in	   acute	   vs.	   chronic	   inflammatory	   conditions	   has	   been	   proposed.	   Pro-­‐inflammatory	  cytokines	  like	  e.g.	  IL-­‐1β	  cause	  acute	  activation	  of	  astrocytes,	  which	  leads	   to	   increased	   secretion	   of	   TIMP-­‐1	   into	   the	   tissue.	   This	   elicits	   a	   repair	  response	  that	  is	  typical	  in	  early	  injury.	  During	  chronic	  inflammation,	  however,	  a	  decline	  of	  TIMP-­‐1	   levels	  below	  homeostatic	   conditions	   is	  observed	   (Gardner	  &	  Ghorpade,	  2003).	  	  	  	  
Cytokines	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Soluble	   pro-­‐	   and	   anti-­‐inflammatory	   proteins	   such	   as	   cytokines	   are	   the	   key	  players	   that	   orchestrate	   initiation,	   maintenance	   and	   termination	   of	  inflammation.	   Cytokines	   form	   a	   vast	   and	   heterogeneous	   group	   of	   secreted	  proteins	   that	   are	   produced	   by	   many	   different	   cell	   types.	   They	   mediate	   and	  regulate	  innate	  and	  adaptive	  immune	  responses.	  Cytokines	  are	  not	  stored	  in	  the	  cell	   that	   expresses	   them	   but	   their	   synthesis	   is	   initiated	   upon	   cell	   activation.	  Newly	  transcribed	  mRNA	  of	  cytokines	  is	  often	  instable	  or	  rapidly	  degraded,	  thus	  both	   transcriptional	   activation	   and	   synthesis	   of	   cytokines	   is	   transient.	  Additionally	   they	   may	   require	   transcriptional	   or	   translational	   processing,	   like	  proteolytic	   cleavage	   of	   an	   inactive	   precursor	   molecule	   into	   an	   active	   product.	  This	   shows	   that	   cytokine	   expression	   is	   a	   highly	   regulated	   process,	   but	   once	  synthesized,	   they	   are	   rapidly	   secreted,	   resulting	   in	   a	   burst	   of	   release	   when	  needed.	  	  	  Cytokines	   can	   be	   produced	   both	   by	   innate	   and	   adaptive	   immune	   cells	   and	  contribute	  to	  host	  defense	  via	  mediating	  and	  regulating	  both	  innate	  and	  adaptive	  responses.	  They	  can	  be	  pleiotropic,	  thus	  one	  cytokine	  can	  act	  on	  a	  variety	  of	  cell	  types	  and	  have	  multiple	  biological	  effects,	  as	  well	  as	  redundant	  in	  their	  actions,	  meaning	   that	   different	   cytokines	  may	   have	   the	   same	   effect.	   After	   release,	   they	  can	  act	  in	  an	  autocrine	  manner,	  thus	  on	  the	  same	  cell	  that	  had	  released	  them,	  or	  in	   a	   paracrine	   one,	   acting	   on	   surrounding	   cells,	   e.g.	   inducing	   further	   cytokine	  production	   or	   recruiting	   neutrophils.	   Also,	   if	   secreted	   in	   higher	   amounts,	   they	  can	   act	   in	   the	   distance	   in	   an	   endocrine	   way	   by	   entering	   the	   circulation	   and	  thereby	  spreading	  over	  the	  whole	  body.	  Such	  systemic	  effects	  can	  be	  induction	  of	  fever,	   cortisol	   production	   or	   sickness	   behaviour	   like	   loss	   of	   appetite	   and	  tiredness.	  TNFα	  is	  an	  example	  for	  a	  cytokine	  that	  can	  both	  have	  local	  and	  distant	  effects.	  	  The	   brain	   cytokine-­‐system	   has	   been	   suggested	   to	   play	   a	   crucial	   role	   in	  depression,	   orchestrating	   neuronal	   circuits	   and	   neurotransmitters	   that	   are	  responsible	   for	   behaviour	   (Dantzer	   &	   Kelley,	   2007;	   Dantzer,	   J.	   C.	   O.	   Connor,	  Freund,	  R.	  W.	  Johnson,	  &	  Kelley,	  2008).	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Inflammation	  in	  the	  CNS	  	  In	   the	  CNS	   there	   is	  T-­‐cell	  and	  antibody	  mediated	  adaptive	   immunity	  as	  well	  as	  toll-­‐like	  receptor	  (TLR)-­‐stimulated	  innate	  immunity.	  Damage	  is	  mainly	  caused	  by	  non-­‐specific	  reactions	  of	  the	  innate	  immunity,	  which	  mainly	  involves	  activation	  of	   effector	   cells	   such	   as	   macrophages	   and	   microglia	   cells,	   which	   cause	   tissue	  injury.	  Macrophages	   can	   produce	   proteases,	  which	   cleave	   proteins	   of	   the	   ECM	  into	   small	   peptides	   that	   can	   be	   loaded	   on	   MHC	   molecules	   and,	   thus,	   used	   to	  augment	   a	   T-­‐cell	   mediated	   inflammatory	   reaction	   by	   an	   increase	   of	   antigen	  presentation	  within	  the	  tissue.	  These	  proteases	  degrade	  parts	  of	  the	  extracellular	  matrix	  (ECM)	  and	  can	  thereby	  directly	  damage	  the	  tissue	  of	   the	  CNS	  as	  well	  as	  dissolve	  tight	  junctions	  of	  the	  endothelial	  cell	  layer	  in	  the	  BBB	  and	  are	  essential	  for	   inflammatory	   cells	   to	   enter	   into	   the	   CNS.	  Macrophages	   can	   augment	   tissue	  damage	   and	   pro-­‐inflammatory	   environment	   by	   production	   of	   inducible	   nitric	  oxide	   synthetase	   (iNOS),	   which	   is	   the	   key	   enzyme	   in	   the	   production	   of	   NO	  radicals.	  They	  can	  also	  produce	  cytotoxic	   cytokines,	   like	  TNFα,	  which	   interacts	  with	   TNF-­‐receptors	   on	   various	   cell	   types	   within	   the	   CNS	   and	   can	   induce	  apoptosis	  and,	  therefore,	  lead	  to	  unspecific	  tissue	  damage.	  TNFα	  can	  bind	  to	  two	  different	   receptors:	   TNF-­‐R1	   and	   TNF-­‐R2.	   TNF-­‐R2	   is	   mainly	   expressed	   by	  endothelial	  cells	  and	  on	  the	  vascular	  wall,	   thus	  stimulation	  of	  TNF-­‐R2	  signaling	  leads	   to	   vasculitis	   and	   ischemia.	   TNF-­‐R1,	   however,	   is	   expressed	   on	  oligodendrocytes	   and,	   in	   a	   lower	   extent,	   on	   neurons	   and	   can	   carry	   out	   its	  cytotoxic	  effects	  on	   these	   cells.	  Despite	   the	  many	  negative	  effects	  of	  TNFα	   it	   is	  also	  important	  for	  the	  induction	  of	  T-­‐cell	  apoptosis	  and,	  thereby,	  termination	  of	  an	   immune	   response	   and	   can	   under	   certain	   conditions	   have	   neuroprotective	  effects	  (Yirmiya	  &	  Goshen,	  2010).	  	  	  
The	  Blood	  brain	  barrier	  	  The	   blood	   brain	   barrier	   (BBB)	   is	   a	   very	   complex	   structure,	   which	   consists	   of	  several	  components.	  Endothelial	  cells,	  which	  are	  the	  predominant	  barrier,	  form	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elaborate	   tight	   junctions	   and	   prevent	   diffusion.	   Some	   molecules	   can	   be	  transported	  from	  the	  blood	  through	  the	  endothelium	  into	  the	  cerebrospinal	  fluid	  (CSF)	  through	  vesicular	  transport,	  but	  this	  active	  transport	  rate	  is	  very	  low.	  The	  second	   barrier	   is	   the	   basement	   membrane,	   which	   has	   charged	   pores	   and	  functions	   as	   a	   molecular	   sieve,	   either	   repelling	   or	   binding	   charged	  molecules.	  Astrocytes	   form	   a	   layer	   around	   the	   basement	   membrane	   with	   their	   cell	  processes	   and	   can	   take	   up	   different	   small	   molecules	   and	   ions.	   Thereby,	   they	  maintain	  the	  ion-­‐concentration	  of	  the	  ECM	  absolutely	  constant,	  which	  is	  crucial	  for	  the	  electrical	  activity	  of	  neurons	  and	  their	  axons.	  Furthermore,	  perivascular	  macrophages	   and	   microglia	   cells	   patrol	   the	   surrounding	   of	   the	   BBB.	   If	   any	  foreign	   material	   managed	   go	   get	   through	   into	   the	   brain,	   it	   is	   taken	   up	   and	  degraded	  by	  them.	  	  The	  BBB	  has	  several	  functions.	  It	  acts	  as	  a	  barrier	  for	  hydrophilic	  molecules	  like	  proteins	   and	   peptides	   and	   thus	   restricts	   entry	   of	   antibodies	   and	   inflammatory	  mediators	   into	   the	   CNS,	   as	   well	   as	   it	   restricts	   exit	   of	   CNS	   molecules.	   This	   is	  crucial,	  since	  the	  BBB	  is	  built	  up	  at	  the	  same	  time	  as	  the	  immune	  system	  during	  embryonic	  development.	  Brain	  antigen	  can´t	  pass	   the	  BBB	  and	   therefore	  never	  enters	   the	   thymus,	   where	   tolerance	   against	   self-­‐antigen	   is	   built	   up	   and,	   with	  some	   exceptions,	   there	   are	   no	   good	   tolerance	   mechanisms	   against	   brain-­‐proteins.	   Thus,	   every	   brain-­‐specific	   protein	   from	   the	   CNS	   has	   the	   potential	   to	  induce	   an	   auto-­‐immune	   reaction	   which,	   if	   induced	   by	   error	   of	   the	   immune-­‐system,	  can	  cause	  an	  autoimmune	  disease	  of	  the	  brain.	  In	  case	  of	  an	  infection	  of	  the	   brain	   there	   has	   to	   be	   a	   defense	   mechanism	   to	   clear	   the	   brain	   from	   these	  pathogens.	   Such	   a	   reaction,	   as	   always	   in	   the	   immune	   system,	   then	   leads	   to	  activation	  of	  immune	  cells	  with	  toxic	  factors,	  which	  contribute	  to	  the	  elimination	  of	  pathogens	  but	  are	  also	  acting	  on	  the	  surrounding	  tissue,	   leading	  to	  collateral	  damage.	  In	  contrast	  to	  the	  periphery,	  where	  tissue	  damage	  can	  be	  repaired	  after	  an	   inflammation,	   these	   repair	  mechanisms	  are	  missing	   in	   the	  brain.	  Therefore,	  collateral	  damage	  has	  to	  be	  kept	  as	  small	  as	  possible	  within	  the	  brain.	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Mood	  disorders	  and	  Inflammation	  	  Inflammation	  has	  been	  implicated	  not	  only	  in	  neurodegenerative	  diseases	  such	  as	  Alzheimer’s	  and	  multiple	  sclerosis	  (Haider	  et	  al.,	  2011),	  but	  also	  in	  mood	  disorders	  and	  suicidal	  behaviour.	  Reports	  indicate	  that	  an	  imbalance	  in	  pro-­‐inflammatory	  mediators	  play	  a	  role	  for	  both	  normal	  brain	  functions	  and	  certain	  psychiatric	  disorders.	  One	  suggested	  mechanism	  involves	  peripheral	  pro-­‐inflammatory	  cytokines	  that	  activate	  microglia	  and	  astrocytes	  in	  the	  nervous	  system,	  which	  results	  in	  a	  release	  of	  pro-­‐inflammatory	  cytokines	  such	  as	  IL-­‐1,	  IL-­‐6	  and	  TNF	  in	  the	  brain	  (Yirmiya	  &	  Goshen,	  2010).	  Serum	  levels	  of	  inflammatory	  mediators	  have	  been	  shown	  to	  be	  elevated	  in	  depressed	  patients	  (M	  Maes	  et	  al.,	  1997;	  O’Brien	  et	  al.,	  2004).	  Around	  40%	  of	  patients	  undergoing	  cytokine	  treatment	  for	  the	  treatment	  of	  e.g.	  cancer	  or	  chronic	  viral	  infections	  have	  been	  reported	  to	  develop	  depressive	  symptoms	  as	  well	  as	  suicidal	  ideation	  (Lucile	  Capuron,	  Hauser,	  Hinze-­‐Selch,	  A.	  H.	  Miller,	  &	  Neveu,	  2002;	  Pollak	  &	  Yirmiya,	  2002).	  Interestingly,	  pretreatment	  with	  the	  antidepressant	  paroxetine	  did	  not	  affect	  symptoms	  like	  fever,	  fatigue	  or	  pain,	  but	  alleviated	  depression	  suggesting	  that	  sickness	  behavior	  and	  depression	  induced	  by	  cytokines	  are	  mediated	  by	  different	  mechanisms	  (L	  Capuron,	  Gumnick,	  et	  al.,	  2002).	  A	  proposed	  mechanism	  underlying	  this	  observation	  is	  the	  stimulation	  of	  the	  enzyme	  indoleamine-­‐2,3-­‐dioxygenase	  (IDO)	  by	  pro-­‐inflammatory	  cytokines	  (AM	  Myint,	  Schwarz,	  Steinbusch,	  &	  B.	  Leonard,	  2009).	  IDO	  degrades	  tryptophan	  into	  kynurenine	  and	  quinolinic	  acid	  and,	  thus,	  decreases	  the	  bioavailability	  of	  this	  essential	  amino	  acid	  for	  serotonin	  synthesis.	  It	  has	  been	  reported	  that	  microglia	  in	  depressed	  patients	  produce	  an	  excess	  of	  quinolinic	  acid	  which	  is	  suggested	  to	  lead	  to	  the	  destruction	  of	  astrocytes	  (B.	  E.	  Leonard	  &	  Ayemu	  Myint,	  2009).	  	  
Endotoxin	  administration	  as	  an	  experimental	  model	  of	  depression	  	  Intraperitoneal	  (i.p.)	  administration	  of	  endotoxin,	  such	  as	  LPS,	  is	  the	  most	  commonly	  used	  immune-­‐depression	  model	  in	  rodents	  (DellaGioia	  &	  Hannestad,	  2010).	  The	  immune	  response	  subsequently	  leads	  to	  symptoms	  similar	  to	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depression	  in	  humans:	  reduced	  appetite,	  the	  inability	  to	  experience	  pleasure	  (anhedonia),	  sleep	  disturbance	  and	  a	  reduction	  in	  social	  exploration	  (Larson	  &	  A.	  Dunn,	  2001).	  The	  peripheral	  production	  of	  cytokines	  induce	  the	  expression	  of	  inflammatory	  mediators	  in	  the	  brain,	  which	  leads	  to	  sickness	  behaviour	  (Pecchi,	  Dallaporta,	  Jean,	  Thirion,	  &	  Troadec,	  2009).	  Depressive-­‐like	  behaviour	  can	  continue	  after	  sickness	  behaviour	  has	  vanished,	  depending	  on	  the	  dose	  of	  endotoxin	  administrated	  (Frenois	  et	  al.,	  2007).	  	  There	  are	  several	  pathways	  through	  which	  peripheral	  immune	  stimulation	  can	  affect	  the	  brain	  and	  cause	  depressive-­‐like	  behaviour.	  Leukocytes	  as	  well	  as	  endothelial	  cells	  have	  toll-­‐like	  receptors	  (TLRs)	  that	  recognize	  so-­‐called	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs).	  The	  binding	  of	  the	  endotoxin	  to	  the	  TLR	  leads	  to	  the	  activation	  of	  the	  transcription	  factor	  NFκB,	  which	  in	  turn	  initiates	  the	  transcription	  of	  several	  pro-­‐inflammatory	  mediators	  (DellaGioia	  &	  Hannestad,	  2010;	  Gaestel,	  Kotlyarov,	  &	  M	  Kracht,	  2009)	  .).	  In	  this	  way,	  the	  signal	  can	  cross	  the	  BBB.	  Other	  possibilities	  are	  signaling	  through	  vagal	  afferents	  and	  by	  direct	  entry	  of	  peripheral	  leukocytes	  into	  the	  brain	  parenchyma	  (Kapás	  et	  al.,	  2011;	  M.	  Opp	  &	  L.	  Toth,	  1998).	  
	  
The	  Forced	  swim	  test	  	  The	  forced	  swim	  test	  (FST)	  was	  developed	  more	  than	  30	  years	  ago	  by	  Porsolt	  et	  al.	   (Porsolt,	  Le	  Pichon,	  &	   Jalfre,	  1977)	  and	  has,	  ever	  since,	  widely	  been	  used	   to	  assess	   depressive-­‐like	   behaviour	   in	   rats	   resp.	   mice	   (J	   F	   Cryan	   &	   Mombereau,	  2004).	   The	   original	   test	   failed	   to	   detect	   a	   reliable	   effect	   of	   selective	   serotonin	  reuptake	   inhibitors	   (SSRIs),	   which	   is	   why	   in	   this	   thesis,	   we	   used	   a	   modified	  version	  of	  the	  test	  (John	  F	  Cryan	  &	  Slattery,	  2007;	  John	  F	  Cryan,	  Markou,	  &	  Lucki,	  2002).	   The	   test	   is	   based	   on	   the	   observation	   that	   animals,	   when	   placed	   in	   a	  cylinder	  filled	  with	  water,	  will	  initially	  try	  to	  escape	  but	  will	  possibly	  develop	  an	  immobile	   posture	   (John	   F	   Cryan	   et	   al.,	   2002).	   This	   immobility	   is	   believed	   to	  reflect	   either	   behavioral	   despair,	  meaning	   that	   the	   animal	   fails	   to	   persist	  with	  escape-­‐directed	   behavior,	   or	   the	   inability	   to	   cope	   with	   stressful	   stimuli.	   The	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animal	  is	  exposed	  to	  the	  forced	  swimming	  for	  15	  minutes	  in	  order	  to	  habituate	  it,	  before	  it	  is	  tested	  the	  following	  day	  for	  10	  minutes.	  If	  antidepressant	  treatments	  are	   applied	   during	   the	   two	   swim	   sessions,	   the	   time	   spent	   immobile	   will	   be	  shorter	  when	  compared	  to	  controls	  that	  are	  only	  vehicle-­‐treated.	  
	  
Quantitative	  RT	  PCR	  and	  the	  Comparative	  ΔΔCt	  method	  	  Quantitative	  real	  time	  polymerase	  chain	  reaction	  (qRT	  PCR)	  is	  a	  widely	  used	  tool	  to	  quantify	  gene	  expression	  by	  measuring	  the	  amount	  of	  mRNA	  in	  a	  given	  tissue	  sample.	  After	  RNA	  isolation	  from	  the	  extracted	  tissue	  the	  RNA	  is	  reverse	  transcribed	  into	  complementary	  DNA	  (cDNA),	  which	  is	  much	  more	  stable	  than	  RNA.	  cDNA	  differs	  from	  genomic	  DNA	  in	  that	  it	  does	  not	  contain	  any	  non-­‐coding	  regions,	  called	  introns,	  since	  those	  have	  been	  cut	  out	  during	  a	  process	  called	  splicing.	  qRT	  PCR	  is	  performed	  in	  a	  thermocycler	  using	  fluorescent	  probe	  sequences,	  which	  are	  activated	  during	  hydrolysis.	  The	  fluorescence	  that	  is	  detected	  in	  real-­‐time	  by	  the	  machine	  is	  proportional	  to	  the	  amount	  of	  PCR	  product	  and	  is	  plotted	  against	  the	  cycle	  number.	  	  In	  this	  thesis,	  relative	  quantification	  of	  gene	  expression	  was	  performed,	  which	  means	  that	  differences	  in	  expression	  of	  a	  target	  gene	  between	  different	  samples	  were	  quantified.	  For	  this,	  a	  common	  threshold	  was	  applied	  on	  all	  samples	  and	  the	  cycle	  number	  when	  this	  threshold	  CT	  was	  reached,	  determined.	  The	  curve	  that	  results	  when	  plotting	  the	  fluorescent	  intensity,	  which	  represents	  the	  amount	  of	  PCR	  product,	  against	  the	  cycle	  number,	  shows	  a	  baseline	  when	  the	  PCR	  product	  is	  low,	  an	  exponential	  and	  finally	  a	  plateau	  phase.	  It	  is	  important	  that	  the	  threshold	  is	  set	  in	  the	  exponential	  phase	  of	  all	  curves,	  since	  this	  represents	  the	  amplicon	  most	  accurately.	  The	  CT	  value	  is	  indirect	  proportional	  to	  the	  amount	  of	  starting	  mRNA	  in	  the	  sample.	  When	  there	  is	  more	  mRNA	  present	  in	  the	  sample,	  the	  amplification	  will	  reach	  the	  threshold	  after	  fewer	  cycles,	  thus	  a	  lower	  CT	  value	  means	  more	  mRNA.	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Before	  the	  CT	  values	  can	  be	  compared,	  they	  need	  to	  be	  normalized	  to	  at	  least	  one	  endogenous	  control.	  This	  is	  done	  in	  order	  to	  account	  for	  differences	  in	  amount	  of	  starting	  material,	  variability	  in	  RNA	  quality,	  cDNA	  synthesis	  efficiencies	  or	  PCR.	  The	  most	  frequent	  normalization	  method	  is	  the	  use	  of	  endogenous	  reference	  genes,	  often	  “housekeeping	  genes”,	  that	  are	  supposed	  to	  be	  expressed	  in	  the	  same	  amount	  in	  every	  cell,	  since	  they	  are	  needed	  to	  maintain	  basic,	  essential	  functions	  that	  the	  cell	  needs	  to	  survive.	  Since	  it	  has	  been	  shown	  that	  the	  expression	  of	  these	  genes	  can	  vary	  under	  different	  experimental	  conditions	  (Dheda	  et	  al.,	  2005)	  the	  use	  of	  more	  than	  one	  reference	  gene	  was	  proposed	  (B.	  E.	  Bonefeld,	  Elfving,	  &	  Wegener,	  2008;	  Nelissen,	  Smeets,	  Mulder,	  Hendriks,	  &	  Ameloot,	  2010).	  The	  following	  formula	  is	  used	  to	  normalize	  against	  a	  control	  gene:	  	  
ΔCT	  =	  CT	  target	  gene	  -­‐	  CT	  endogenous	  control	  gene	  	  To	  depict	  the	  results,	  the	  fold	  change	  between	  treated	  animal	  and	  control	  animal	  was	  calculated	  using	  the	  Comparative	  CT	  method	  for	  relative	  quantification	  (Livak	  &	  Schmittgen,	  2001):	  	  
ΔΔCT	  =	  ΔCT	  target	  gene	  of	  treated	  animal	  -­‐	  ΔCT	  target	  gene	  of	  untreated	  animal	  	  Fold	  change	  =	  2-­‐ΔΔCT	  	  A	  fold	  change	  of	  2	  means	  that	  the	  treated	  animal	  has	  a	  2-­‐fold	  increase	  in	  expression	  of	  the	  target	  gene	  as	  compared	  to	  the	  untreated	  sample,	  meaning	  twice	  as	  much.	  A	  reduction	  in	  fold	  change,	  e.g.	  0.5	  can	  be	  calculated	  as	  the	  negative	  reverse	  of	  2-­‐ΔΔCT,	  thus	  –(1/(2-­‐ΔΔCT)),	  which	  equals	  -­‐2,	  which	  means	  a	  2-­‐fold	  decrease,	  or	  half	  as	  much.	  	  
Aims	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The	  aim	  of	  this	  thesis	  was	  to	  investigate	  mechanisms	  related	  to	  the	  connection	  between	  inflammation	  and	  depression.	  In	  order	  to	  do	  this,	  mRNA	  levels	  of	  certain	  cytokines	  and	  other	  proteins	  that	  are	  involved	  in	  immune	  response	  were	  measured	  before	  and	  after	  peripheral	  immune	  activation	  in	  the	  brains	  of	  rats.	  Additionally,	  we	  tested	  whether	  exposure	  to	  the	  forced	  swim	  test	  (FST),	  a	  widely	  used	  animal	  model	  to	  test	  for	  depressive-­‐like	  behaviour,	  might	  alter	  the	  expression	  of	  these	  proteins.	  The	  possible	  correlation	  between	  protein	  expression	  in	  the	  CNS	  as	  well	  as	  serum	  levels	  of	  certain	  cytokines	  and	  behaviour	  during	  the	  FST	  was	  investigated.	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Material	  and	  Methods	  	  
Ethics	  	  The	   animal	   study	   was	   approved	   by	   the	   Animal	   Ethics	   committee	   at	   the	  University	  of	  Gothenburg.	  	  
Animals	  	  Male	  Sprague-­‐Dawley	   (SD)	  rats	   (260-­‐300g	  at	   the	   time	  of	   the	  experiment)	   from	  Taconic	   breeding	   colonies,	   Denmark,	   were	   used	   in	   these	   experiments.	   The	  animals	  were	  kept	  6	  per	  cage	  in	  standard	  laboratory	  cages	  with	  sawdust	  bedding	  and	  free	  access	  to	  food	  and	  water.	  The	  housing	  room	  had	  a	  12:12	  light	  dark	  cycle	  (lights	   on	   at	   6:30	   a.m.)	   and	   all	   experiments	   were	   performed	   during	   the	   light	  phase.	  All	  animals	  were	  allowed	  to	  acclimatize	  for	  7	  days	  prior	  to	  experiments,	  being	  handled	  briefly	  every	  second	  day	  to	  get	  used	  to	  experimenter	  handling.	  	  
Outline	  of	  the	  experiment	  	  The	  animals	  were	  divided	   into	   four	  groups	  (n=6	  per	  group):	  saline	  treated	  and	  no	  forced	  swim	  test	  (FST);	  LPS	  treated	  and	  no	  FST;	  saline	  treated	  and	  FST;	  LPS	  treated	   and	  FST.	  The	  FST	  was	   conducted	   exactly	  6	  h	   after	   the	  LPS	   resp.	   saline	  injection	   and	   all	   animals	   were	   sacrificed	   by	   rapid	   decapitation	   7h	   after	   the	  injections,	   i.e.	  1	  h	  after	   the	  FST.	  Blood	  was	  collected	  and	  brains	  were	  removed.	  Blood	  was	   kept	   at	   room	   temperature	   for	   1	   h,	   thereafter	   kept	   at	   4°C	   and	   spun	  down	  at	  4°C	   for	  10	  min	  at	  4000rpm.	  Serum	  was	   then	  collected	  and	  stored	  at	   -­‐20°C	  until	  further	  analysis.	  Brains	  were	  removed	  from	  the	  scull	  and	  dissected	  on	  ice.	   Brain	   areas	   of	   interest	   (amygdala,	   hippocampus,	   hypothalamus,	   prefrontal	  cortex	  and	  striatum)	  were	  immediately	  submerged	  in	  1	  ml	  of	  RNA	  stabilization	  reagent	   (RNAlater,	   Quiagen,	   Hilden,	   Germany)	   in	   1.5	   ml	   tubes	   which	   were	  weighed	  before	  and	  after	  the	  tissue	  was	  added.	  The	  tissue	  samples	  were	  kept	  at	  
	  24	  
+8°C	  for	  24	  h	  so	  the	  liquid	  could	  soak	  through	  the	  tissue	  and	  then	  stored	  at	  -­‐20°C	  for	  further	  analysis.	  	  
LPS	  administration	  	  Lipopolysaccharide	   (LPS;	   from	   Escherichia	   coli	   serotype	   055:B5,	   Sigma)	   was	  dissolved	  in	  0.9%	  sodium	  chloride	  (saline	  vehicle).	  Injections	  were	  administered	  intraperitoneally	   (i.p.)	   in	   a	   concentration	   of	   0.5	   mg/kg	   body	   weight	   and	   an	  injection	  volume	  of	  approx.	  1.5	  ml.	  Control	  animals	  were	  injected	  with	  1.5ml	  of	  vehicle	  alone.	  	  
	  
Forced	  swim	  test	  	  A	  modified	  version	  of	  the	  forced	  swim	  test	  (FST)	  (Porsolt	  et	  al.,	  1977)	  to	  screen	  for	  depressive-­‐like	  behavior	  was	  conducted	  as	  described	  by	  Cryan	  et	  al.(John	  F	  Cryan	  et	  al.,	  2002)	  on	  two	  consecutive	  days	  in	  a	  transparent	  acrylic	  cylinder	  (60	  cm	  high,	  24	  cm	  diameter,	  water	  depth	  45	  cm),	  which	  was	  cleaned	  and	  filled	  with	  fresh	  water	   (25±1°C)	   before	   each	   animal	   tested.	   The	   swimming	   sessions	  were	  conducted	   in	   a	  dark	   room	  with	   the	  water	   tank	  being	  directly	   surrounded	  by	  3	  black	  walls	   to	   avoid	   distraction,	   with	   a	   lamp	   illuminating	   only	   the	  water	   tank	  from	  above.	  On	  day	  one	  of	  the	  FST	  the	  animals	  were	  made	  to	  swim	  for	  15	  min	  in	  order	   to	   familiarize	   them	   to	   the	   test.	   On	   day	   two,	   the	   experimental	   day,	   the	  animals	  were	   placed	   in	   the	  water-­‐filled	   cylinder	   and	   let	   swim	   for	   10	  min.	   The	  animals	  were	  dried	  with	   a	   towel	   and	  placed	  underneath	   an	   infrared	   lamp	   in	   a	  cage	  with	  towel	  bedding	  for	  approx.	  10	  min.	  The	  FST	  was	  recorded	  with	  a	  video	  camera	   that	   was	   set	   in	   horizontal	   level	   with	   the	   cylinder.	   The	   scoring	   of	   the	  animals	  was	  conducted	  by	  a	  researcher	  blind	  to	  the	  treatment.	  The	  10	  min	  swim	  session	  was	   divided	   into	   5	   s	   intervals	   and	   the	   predominant	   behavior	   for	   each	  interval	  scored	  with	  respect	  to	  immobility,	  swimming	  or	  climbing.	  The	  behaviour	  was	  defined	  as	  immobility	  as	  in	  the	  original	  Porsolt	  test,	  which	  is	  that	  the	  animal	  showed	   no	   additional	   activity	   than	   that	   necessary	   to	   keep	   its	   head	   above	   the	  water.	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Probe	  preparation	  	  For	   total	   RNA	   extraction,	   the	   brain	   tissue	   samples	   were	   removed	   from	  stabilization	  reagent	  and	  homogenized	  with	  a	  stainless	  steel	  bead	  (5mm,	  Qiagen,	  Hilden,	   Germany)	   in	   1ml	   lysis	   reagent	   each	   using	   a	   bead	   mill	   (Tissue	   Lyser,	  Qiagen).	  Disruption	  was	  followed	  by	  RNeasy	  Lipid	  Tissue	  Mini	  Kit	  (Qiagen)	  using	  an	   automated	   sample	   preparation	   robot	   (QIAcube,	   Qiagen)	   according	   to	  manufacturer´s	   instructions.	   Quality	   and	   concentration	   of	   RNA	   were	   assessed	  using	  a	  NanoDrop	  (Thermal	  Scientific,	  Odessa,	  TX,	  USA).	  For	  quantitative	  RT	  PCR	  1	   μg	   of	   total	   RNA	   per	   sample	   was	   reverse-­‐transcribed	   into	   cDNA	   in	   a	   20	   μl	  reaction	   mixture	   using	   the	   QuantiTect	   Reverse	   Transcription	   Kit	   (Qiagen)	  following	  the	  manufacturer´s	  instructions.	  	  
Quantitative	  real-­‐time	  RT	  PCR	  	  Real-­‐time	   RT	   PCR	   was	   conducted	   on	   an	   ABI	   7900HT	   thermocycler	   (Applied	  Biosystems)	  using	  500	  ng	  cDNA	   in	  a	  100	  μl	   reaction	  mixture	  using	   fluorescent	  probe	   sequences	   (TaqMan	   Gene	   Expression	   Master	   Mix,	   Applied	   Biosystems)	  that	   are	   activated	   during	   hydrolysis.	   384-­‐well	   TaqMan®	   Custom	   Array	   micro	  fluid	  cards	  had	  been	  previously	  configured	  and	  ordered	  at	  Applied	  Biosystems.	  The	   target	   genes	   were	   HTR-­‐1b	   (Rn01637747_s1).	   HTR-­‐2a	   (Rn00568473_m1),	  IL-­‐1β	   (Rn01514151_m1),	  MMP-­‐9	   (Rn01423075_g1),	  TIMP-­‐1	   (Rn01430875_g1),	  NFKB	  (Rn01399583_m1),	  iNOS	  (Rn00561646_m1),	  and	  TNFα	  (Rn01525859_g1)	  and	   of	   the	   four	   endogenous	   controls	   (GAPDH:	   Rn99999916_s1,	   PPIA:	  Rn00690933_m1,	   18S:	   Hs99999901_s1,	   ACTB:	   Rn00667869_m1)	   GAPDH	   and	  PPIA	  were	  selected.	  	  
ELISA	  	  IL-­‐1β	  and	  TNFα	  concentrations	  in	  rat	  serum	  were	  measured	  using	  commercially	  available	   rat	   IL-­‐1β,	   respectively	   rat	   TNFα,	   sandwich	   enzyme-­‐linked	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immunosorbent	  assay	  (ELISA)	  kits	  (R&D	  Systems	  Europe,	  Abingdon,	  UK).	  50	  μl	  serum	  were	  added	  to	  a	  100	  μl	  reaction	  and	  optical	  density	  measured	  at	  450	  nm	  (with	  540nm	  as	  a	  correction	  wavelength)	  using	  a	  microplate	  reader	  (SpectraMax	  340PC384	   Absorbance	   Microplate	   Reader,	   Molecular	   Devices,	   Sunnyvale,	   CA,	  USA).	  	  
Statistical	  Analysis	  and	  Graphs	  	  All	  statistical	  analysis	  was	  carried	  out	  using	  the	  statistical	  softwear	  package	  SPSS	  (Version	   19;	   SPSS,	   Chicago,	   IL,	   USA).	   The	   effect	   of	   LPS	   administration	   and	  swimming	  on	  mRNA	  levels	  in	  the	  different	  brain	  regions	  was	  assessed	  applying	  a	  two-­‐way	  analysis	  of	  variance	  (ANOVA)	  on	  the	  ΔCT	  values.	  The	  estimated	  effects	  of	  treatment	  and	  behaviour	  testing	  from	  the	  two-­‐way	  ANOVA	  were	  expressed	  as	  up	  folds	  or	  down	  folds.	  To	  demonstrate	  these	  effects	  in	  a	  graph,	  the	  fold	  changes	  (2-­‐ΔΔCT)	  were	  calculated	  using	  the	  non-­‐swimming,	  saline	  treated	  group	  as	  reference.	  Each	  spot	  in	  the	  scatterplots	  represents	  an	  individual	  rat	  and	  the	  horizontal	  lines	  represent	   the	   group	   geometrical	   means.	   A	   Levene´s	   test	   of	   Equality	   of	   Error	  Variances	  was	   applied	   in	   every	   analysis	   to	   check	   for	   unequal	   variances	  within	  the	   sample	   groups.	   The	   effect	   of	   LPS	   treatment	   on	   immobility,	   swimming	   or	  climbing	   during	   the	   FST	   was	   assessed	   using	   an	   independent	   samples	   T-­‐test.	  Since	  iNOS	  expression	  was	  too	  low	  to	  reach	  detection	  limit	  in	  many	  of	  the	  saline-­‐treated	   samples,	   a	   Chi-­‐square	   analysis	  was	   conducted.	   iNOS	  mRNA	   expression	  above	  detection	  limit	  was	  compared	  to	  mRNA	  expression	  below	  detection	  limit	  (equals	  no	  expression)	  in	  saline-­‐treated	  animals	  that	  were	  exposed	  to	  the	  FST	  to	  their	  non-­‐swimming,	  saline-­‐treated	  controls.	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Results	  
	  
Effect	  of	  LPS	  injection	  and	  the	  FST	  on	  mRNA	  levels	  in	  the	  brain	  	  
Cytokine	  expression	  after	  LPS	  and	  FST	  	  As	  expected,	  injection	  of	  LPS	  i.p.	  caused	  a	  significant	  up-­‐regulation	  of	  both	  IL-­‐1β	  (Fig.	  1)	  and	  TNFα	  (Fig.	  2)	  mRNA	  in	  all	  investigated	  brain	  regions.	  The	  stressor	  swimming,	  however,	  had	  no	  significant	  effect	  apart	  from	  a	  down-­‐regulation	  of	  IL-­‐1β	  in	  hippocampus	  and	  an	  up-­‐regulation	  of	  TNFα	  in	  the	  prefrontal	  cortex	  (Fig.1).	  A	  Levene´s	  test	  of	  Equality	  of	  Error	  Variances	  revealed	  that	  the	  error	  variance	  of	  the	  dCt	  values	  for	  IL-­‐1β	  was	  not	  equal	  across	  groups	  in	  the	  prefrontal	  cortex,	  suggesting	  that	  a	  more	  stringent	  significance	  level	  should	  be	  set	  for	  evaluating	  the	  results	  of	  the	  two-­‐way	  ANOVA.	  Since	  the	  up-­‐regulation	  in	  the	  prefrontal	  cortex	  had	  a	  very	  high	  significance	  ,	  we	  decided	  to	  keep	  the	  value.	  The	  same	  goes	  for	  the	  spread	  of	  TNFα	  mRNA	  dCt	  values	  	  in	  amygdala,	  hippocampus	  and	  striatum,	  where	  the	  Levene´s	  test	  showed	  significance	  levels	  lower	  than	  0.05.	  These	  results	  are	  considered	  to	  be	  valid	  due	  to	  their	  high	  significances	  in	  the	  two-­‐way	  ANOVA	  (p≤0.002).	  	  
Different	  effects	  of	  LPS	  treatment	  and	  FST	  exposure	  on	  BDNF	  expression	  	  LPS	  treatment	  was	  followed	  by	  down-­‐regulation	  of	  brain-­‐derived	  neurotrophic	  factor	  (BDNF)	  in	  all	  brain	  regions,	  indicated	  in	  amygdala	  (p=0.051)	  and	  significant	  in	  hippocampus	  (p=0.033)	  and	  prefrontal	  cortex	  (0.032).	  Exposure	  to	  the	  FST,	  however,	  caused	  an	  up-­‐regulation	  of	  BDNF	  mRNA	  in	  amygdala	  (p=0.002)	  and	  prefrontal	  cortex	  (p=0.006)	  (Fig.3).	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Figure	   1:	   mRNA	   fold	   changes	   of	   IL-­‐1β	   following	   i.p.	   LPS	   injection	   and	   forced	   swim	   test	  
(FST).	   While	   LPS	   caused	   very	   strong	   up-­‐regulation	   of	   IL-­‐1β	   mRNA	   in	   all	   examined	   brain	  
regions	   (p=0.000),	   no	   effect	   of	   the	   FST	   was	   seen	   apart	   from	   a	   down-­‐regulation	   of	   IL-­‐1β	  
mRNA	   in	   the	   hippocampus	   (p=0.018).	   Control	   animals	   didn´t	   undergo	   the	   FST.	   Statistical	  
significance	   relative	   to	   saline-­‐treated	   resp.	   non-­‐swimming	   equivalents	   is	   indicated	   by	   an	  
asterisk	  (*p<0.05,	  **p<0.01,	  ***p<0.001;	  n=5-­‐6	  animals	  per	  group).	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Figure	   2:	   mRNA	   fold	   changes	   of	   TNFα	   following	   i.p.	   LPS	   injection	   and	   forced	   swim	   test	  
(FST).	  Strong	  up-­‐regulation	  of	  TNFα	  mRNA	  is	  seen	  in	  all	  brain	  regions	  (p≤0.002)	  after	  i.p.	  LPS	  
but	   only	   in	   the	   prefrontal	   cortex	   of	   swimming	   animals	  when	   compared	   to	   non-­‐swimmers	  
(p=0.044).	  Control	  animals	  didn´t	  undergo	  the	  FST.	  Statistical	  significance	  relative	  to	  saline-­‐
treated	   resp.	   non-­‐swimming	   equivalents	   is	   indicated	   by	   an	   asterisk	   (*p<0.05,	   **p<0.01,	  
***p<0.001;	  n=5-­‐6	  animals	  per	  group).	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Figure	   3:	  mRNA	   fold	   changes	   of	   BDNF	   following	   i.p.	   LPS	   injection	   and	   forced	   swim	   test	  
(FST).	   LPS	   administration	   caused	   down-­‐regulation	   of	   BDNF	  mRNA	   expression	   in	   nearly	   all	  
observed	   brain	   regions,	   with	   significance	   in	   hippocampus	   (p=0.033)	   and	   prefrontal	   cortex	  
(p=0.032)	  and	  a	  strong	  indication	  in	  amygdala	  (p=0.051).	  Exposure	  to	  the	  FST	  caused	  an	  up-­‐
regulation	   in	   amygdala	   (p=0.002)	   and	   prefrontal	   cortex	   (p=0.006).	   Control	   animals	   didn´t	  
undergo	   the	   FST.	   Statistical	   significance	   relative	   to	   saline-­‐treated	   resp.	   non-­‐swimming	  
equivalents	  is	  indicated	  by	  an	  asterisk	  (*p<0.05,	  **p<0.01;	  n=5-­‐6	  animals	  per	  group).	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LPS	  induced	  up-­‐regulation	  of	  iNOS	  	  A	  strong	  up-­‐regulation	  of	  iNOS	  mRNA	  following	  LPS	  treatment	  was	  observed	  (Fig.4).	  Several	  samples	  in	  the	  saline-­‐treated	  groups	  were	  below	  detection	  limit	  of	  the	  quantitative	  RT	  PCR	  assay,	  thereby	  limiting	  analysis	  of	  the	  effect	  of	  the	  stressor	  swimming.	  When	  comparing	  detection	  of	  iNOS	  expression	  to	  no	  detection	  in	  saline-­‐treated	  animals,	  a	  chi-­‐square	  analysis	  showed	  no	  significant	  effect,	  even	  though	  33.8%	  of	  all	  non-­‐swimming	  saline-­‐treated	  animals	  but	  50.8%	  of	  saline-­‐treated	  animals	  that	  were	  exposed	  to	  the	  FST	  expressed	  iNOS	  above	  detection	  limit.	  	  
No	  effect	  of	  exposure	  to	  the	  FST	  on	  MMP-­‐9	  and	  TIMP-­‐1	  expression	  	  Administration	  of	  LPS	  i.p.	  caused	  a	  significant	  up-­‐regulation	  of	  the	  matrix-­‐metalloproteinase	  MMP-­‐9	  in	  the	  regions	  hypothalamus	  (p=0.001)	  and	  striatum	  (p=0.000)	  and	  a	  less	  pronounced	  up-­‐regulation	  in	  the	  prefrontal	  cortex	  (p=0.075)	  (Fig.	  5).	  No	  observable	  changes	  in	  MMP-­‐9	  expression	  was	  seen	  between	  animals	  that	  were	  exposed	  to	  the	  FST	  and	  those	  that	  weren´t.	  The	  endogenous	  inhibitor	  of	  this	  metalloproteinase,	  tissue	  inhibitor	  of	  metalloproteinases	  TIMP-­‐1,	  was	  up-­‐regulated	  in	  all	  brain	  regions	  after	  LPS	  injection	  (p=0.000	  in	  all	  regions	  apart	  from	  the	  prefrontal	  cortex:	  p=0.04)	  (Fig.	  6).	  TIMP-­‐1	  expression	  was	  unaffected	  by	  exposure	  to	  the	  FST	  in	  all	  compartments.	  	  	  
No	  effect	  of	  LPS	  treatment	  on	  NFκB	  levels	  	  Administration	  of	  LPS	  i.p.	  caused	  no	  changes	  in	  NFκB	  mRNA	  levels	  in	  any	  of	  the	  observed	  brain	  regions	  (Fig.7).	  A	  slight	  up-­‐regulation	  was	  seen	  in	  the	  prefrontal	  cortex	  when	  comparing	  swimming	  animals	  to	  their	  non-­‐swimming	  controls	  (p=0.007),	  although	  a	  Levene´s	  test	  of	  Equality	  of	  Error	  Variances	  revealed	  that	  the	  error	  variance	  of	  the	  dCt	  values	  for	  NFκB	  was	  not	  equal	  across	  groups	  in	  the	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prefrontal	  cortex	  (p=0.037),	  suggesting	  that	  a	  more	  stringent	  significance	  level	  should	  be	  set	  for	  evaluating	  the	  results	  of	  the	  two-­‐way	  ANOVA.	  	  	  
	  
	  
Figure	   4:	   mRNA	   fold	   changes	   of	   iNOS	   following	   i.p.	   LPS	   injection	   and	   forced	   swim	   test	  
(FST).	  LPS	  administration	  caused	  up-­‐regulation	  of	  iNOS	  mRNA	  in	  all	  observed	  brain	  regions.	  
Up-­‐regulation	   after	   LPS	   treatment	   is	   significant	   in	   amygdala	   (p=0.000),	   hypothalamus	  
(p=0.007)	  prefrontal	  cortex	  (p=0.027)	  and	  striatum	  (p=0.001).	  Exposure	  to	  the	  FST	  caused	  an	  
up-­‐regulation	  only	  in	  the	  prefrontal	  cortex	  (p=0.01).	  Control	  animals	  didn´t	  undergo	  the	  FST.	  
Statistical	  significance	  relative	  to	  saline-­‐treated	  resp.	  non-­‐swimming	  equivalents	  is	  indicated	  
by	  an	  asterisk	  (*p<0.05,	  **p<0.01,	  ***p<0.001).	  The	  low	  amount	  of	  animals	  in	  some	  groups	  
(n=1-­‐6	  animals	  per	  group)	  is	  due	  to	  expression	  below	  detection	  limit	  in	  many	  samples.	  Too	  
many	  samples	  in	  hippocampus	  were	  below	  detection	  limit	  to	  analyze	  the	  data.	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Figure	  5:	  mRNA	  fold	  changes	  of	  MMP-­‐9	   following	   i.p.	  LPS	   injection	  and	  forced	  swim	  test	  
(FST).	  Up-­‐regulation	  of	  mRNA	  by	   i.p.	  LPS	   is	  significant	   in	  hypothalamus	  and	  striatum	  and	  a	  
tendency	  seen	  in	  the	  prefrontal	  cortex	  (p=0.075).	  There	  was	  no	  effect	  seen	  when	  comparing	  
swimming	   animals	   to	   non-­‐swimming	   controls.	   Control	   animals	   didn´t	   undergo	   the	   FST.	  
Statistical	   significance	   relative	   to	   saline-­‐treated	   equivalents	   is	   indicated	   by	   an	   asterisk	  
(*p<0.05,	  **p<0.01,	  ***p<0.001;	  n=5-­‐6	  animals	  per	  group).	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Figure	  6:	  mRNA	  fold	  changes	  of	  TIMP-­‐1	   following	   i.p.	   LPS	   injection	  and	   forced	  swim	  test	  
(FST).	  Significant	  up-­‐regulation	  of	  TIMP-­‐1	  mRNA	  after	   i.p.	  LPS	   injection	   in	  all	  brain	  regions.	  
There	  was	   no	   effect	   seen	  when	   comparing	   swimming	   animals	   to	   non-­‐swimming	   controls.	  
Control	   animals	   didn´t	   undergo	   the	   FST.	   Statistical	   significance	   relative	   to	   saline-­‐treated	  
equivalents	   is	   indicated	  by	  an	  asterisk	   (*p<0.05,	   **p<0.01,	   ***p<0.001;	  n=5-­‐6	  animals	  per	  
group).	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Figure	   7:	  mRNA	   fold	   changes	   of	   NFκB	   following	   i.p.	   LPS	   injection	   and	   forced	   swim	   test	  
(FST).	   LPS	   treatment	  had	  no	  observable	  effect	  on	  NFκB	  mRNA	   levels.	   Exposure	   to	   the	  FST	  
caused	   an	   up-­‐regulation	   only	   in	   the	   prefrontal	   cortex	   (p=0.007).	   Control	   animals	   didn´t	  
undergo	  the	  FST.	  Statistical	  significance	  relative	  to	  non-­‐swimming	  equivalents	  is	  indicated	  by	  
an	  asterisk	  (**p<0.01;	  n=5-­‐6	  animals	  per	  group).	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Effects	  of	  LPS	  on	  the	  behaviour	  in	  the	  FST	  	  Administration	  of	  LPS	  i.p.	  caused	  a	  2.8	  fold	  up-­‐regulation	  of	  immobile	  behaviour	  and	  a	  1.7	  fold	  down-­‐regulation	  of	  swimming	  behaviour	  (Fig.8),	  showing	  a	  strong	  depressive-­‐like	  effect	  of	  LPS	  on	  behaviour.	  No	  observable	  effect	  of	  LPS	  treatment	  was	  seen	  on	  climbing	  behaviour.	  	  
	  	  
Figure	  8:	  Effects	  of	  LPS	  on	  the	  behaviour	  during	  the	  forced	  swim	  test	  (FST):	  Intraperitoneal	  
injection	   of	   LPS	   (0.5mg/kg)	   caused	   a	   significant	   up-­‐regulation	   of	   immobility	   resp.	   down-­‐
regulation	   of	   swimming	   during	   the	   FST.	   No	   effect	   of	   LPS	   on	   climbing	   behaviour	   was	  
observed.	  Behaviour	  is	  measured	  as	  number	  of	  5	  second	  intervals	  of	  immobility,	  swimming	  
and	   climbing	   during	   the	   10	   minute	   trial.	   Data	   is	   represented	   as	   mean	   ±	   SEM.	   Statistical	  
significance	  relative	  to	  saline-­‐injected	  controls	  is	  indicated	  by	  an	  asterisk	  (**p=0.001),	  n	  =	  6	  
animals	  per	  group.	  	  
Correlation	  between	  immobility	  in	  the	  FST	  and	  mRNA	  levels	  	  A	  positive	  correlation	  between	  mRNA	  expression	  in	  the	  different	  brain	  regions	  and	  immobility	  scores	  during	  the	  FST	  was	  seen	  for	  both	  IL-­‐1β	  (Fig.9)	  and	  TNFα	  (Fig.10).	  For	  IL-­‐1β	  ,	  correlation	  was	  strongest	  in	  the	  amygdala,	  hippocampus	  and	  hypothalamus,	  but	  also	  seen	  in	  the	  prefrontal	  cortex	  and	  striatum.	  Correlation	  between	  TNFα	  mRNA	  and	  immobility	  was	  seen	  as	  a	  tendency	  in	  amygdala	  and	  significant	  in	  the	  hippocampus,	  hypothalamus,	  prefrontal	  cortex	  and	  striatum.	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Figure	  9:	  Correlation	  between	  immobility	  scores	  and	  mRNA	  levels	  of	  IL-­‐1β .	  LPS	  induced	  up-­‐
regulation	  of	   IL-­‐1β	  mRNA	  correlates	   significantly	  with	   increased	   immobility	   in	  all	  observed	  
brain	  regions	  (amygdala:	  R=0.712,	  p=0.009;	  hippocampus:	  R=0.762,	  p=0.004;	  hypothalamus:	  
R=0.832,	   p=0.001;	   prefrontal	   cortex:	   R=0.655,	   p=0.021;	   striatum:	   R=0.661,	   p=0.019).	  
Immobility	   is	   measured	   as	   number	   of	   5	   second	   intervals	   in	   the	   FST.	   mRNA	   expression	   is	  
shown	  as	  negative	  values	  of	  mean	  cycle	  threshold	  (dCt).	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Figure	  10:	  Correlation	  between	  immobility	  scores	  and	  mRNA	  levels	  of	  TNFα .	  LPS	  induced	  
up-­‐regulation	   of	   TNFα	   mRNA	   correlates	   significantly	   with	   increased	   immobility	   in	   all	  
observed	   brain	   regions	   apart	   from	   amygdala	   (R=0.573,	   p=0.052;	   hippocampus:	   R=0.738,	  
p=0.01;	   hypothalamus:	   R=0.811,	   p=0.001;	   prefrontal	   cortex:	   R=0.611,	   p=0.019;	   striatum:	  
R=0.644,	   p=0.024).	   Immobility	   is	   measured	   as	   number	   of	   5	   second	   intervals	   in	   the	   FST.	  
mRNA	  expression	  is	  shown	  as	  negative	  values	  of	  mean	  cycle	  threshold	  (dCt).	  
Correlation Immobility/TNF! mRNA
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Correlation	  between	  immobility	  during	  the	  FST	  and	  serum	  levels	  of	  IL-­‐1β 	  
and	  TNFα 	  	  LPS	  caused	  a	  strong	  up-­‐regulation	  of	  both	  cytokines	  in	  the	  periphery	  (p=0.000),	  but	  exposure	  to	  the	  FST	  didn´t	  have	  a	  significant	  effect	  on	  the	  peripheral	  levels	  of	  these	  cytokines	  (Fig.11).	  A	  Levene´s	  test	  of	  Equality	  of	  Error	  Variances	  revealed	  that	  the	  error	  variance	  of	  the	  IL-­‐1β	  and	  TNFα	  protein	  levels	  was	  not	  equal	  across	  groups	  (p=0.009	  for	  IL-­‐1β	  and	  p=	  0.013	  for	  TNFα),	  suggesting	  that	  a	  more	  stringent	  significance	  level	  should	  be	  set	  for	  evaluating	  the	  results	  of	  the	  two-­‐way	  ANOVA.	  To	  determine	  whether	  there	  was	  a	  direct	  correlation	  between	  cytokine	  levels	  in	  the	  periphery	  and	  the	  behaviour	  during	  the	  FST,	  correlation	  analysis	  was	  performed.	  A	  positive	  correlation	  between	  peripheral	  IL-­‐1β	  protein	  levels	  and	  immobility	  was	  observed	  (Fig.	  12A)	  but	  none	  between	  TNFα	  serum	  levels	  and	  behaviour	  scores	  (Fig.12B).	  	  	  
A	   	   	   	   	   	   B	  
	  
Figure	  11:	  Serum	  levels	  of	  IL-­‐1β 	  and	  TNFα .	  LPS	  treatment	  causes	  a	  strong	  elevation	  of	  both	  
IL-­‐1β	   (A)	  and	  TNFα	   (B)	  protein	   levels	   in	  serum.	  No	  significant	  effect	   is	  seen	  of	  exposure	  to	  
the	   FST.	   Control	   animals	   didn´t	   undergo	   the	   FST.	   Data	   is	   represented	   as	   mean	   ±	   SEM.	  
Statistical	   significance	   relative	   to	   saline-­‐treated	   equivalents	   is	   indicated	   by	   an	   asterisk	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Figure	  12:	  Correlation	  between	  immobility	  during	  the	  FST	  and	  serum	  levels	  of	  IL-­‐1β 	  (A)	  and	  
TNFα 	  (B).	  IL-­‐1β	  serum	  levels	  show	  a	  positive	  correlation	  with	  immobility	  (R=0.612,	  p=0.046)	  
but	  there	  was	  no	  significant	  correlation	  between	  TNFα	  protein	  levels	  in	  serum	  and	  
immobility	  scores.	  Immobility	  is	  measured	  as	  number	  of	  5	  second	  intervals	  in	  the	  FST.	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Discussion	  	  
Effects	  of	  LPS	  treatment	  on	  mRNA	  levels	  in	  the	  brain	  	  In	   line	  with	  previous	   results,	   our	   experiments	   have	   shown	  a	   clear	   response	   of	  mRNA	   expression	   of	   immune	   related	   substances	   to	   the	   peripheral	   immune	  stimulation.	  Both	  IL-­‐1β	  and	  TNFα	  mRNA	  levels	  were	  significantly	  elevated	  in	  all	  observed	  brain	   regions	  post	   i.p.	  LPS	   injection.	  Up-­‐regulation	  of	   these	  cytokines	  after	   peripheral	   LPS	   is	   well-­‐documented	   (van	   Dam,	   Brouns,	   Louisse,	   &	  Berkenbosch,	   1992;	   Terrence	   Deak	   et	   al.,	   2003;	  M	   K	   Hansen	   et	   al.,	   2000;	   K.T.	  Nguyen	   et	   al.,	   1998;	   Pugh	   et	   al.,	   1999).	   This	   supports	   the	   concept	   that	   these	  cytokines	   are	   mediators	   in	   the	   illness-­‐induction	   pathway,	   and	   shows	   that	  endotoxin	  administration	  does	  not	  only	  cause	  a	  systemic	  inflammation,	  but	  also	  an	  inflammation	  in	  the	  CNS,	  which	  is	  mediated	  by	  activated	  microglia	  that	  lead	  to	  chronically	   elevated	   levels	   of	   pro-­‐inflammatory	   cytokines	   (Michael	  Maes	   et	   al.,	  2009).	  	  We	  observed	  an	  up-­‐regulation	  of	  both	  the	  matrix	  metalloproteinase	  MMP-­‐9	  and	  its	  tissue	  inhibitor	  TIMP-­‐1	  in	  hypothalamus	  and	  striatum	  after	  LPS.	  MMP-­‐9	  plays	  an	  important	  role	  in	  the	  remodeling	  of	  the	  extracellular	  matrix	  and	  facilitates	  the	  migration	  of	  immune	  cells	  such	  as	  neutrophils	  through	  the	  CNS,	  thus	  alleviating	  the	   induction	   of	   an	   immune	   response.	   The	   up-­‐regulation	   of	   its	   inducible	  inhibitor,	   TIMP-­‐1,	   is	   probably	   induced	   by	   elevated	   levels	   of	   IL-­‐1β	   and	   might	  reflect	  an	  automatic	   feedback	  initiated	  by	  the	  increase	  in	  MMP-­‐9	  expression,	   in	  order	  to	  protect	  the	  tissue	  from	  damage.	  	  	  Investigation	   of	   BDNF	   mRNA	   levels	   showed	   a	   down-­‐regulation	   after	   LPS	  treatment.	   This	   effect	   has	   been	   proposed	   to	   play	   a	   role	   in	   the	   reduction	   of	  neurogenesis	  caused	  by	  inflammatory	  reactions,	  which	  in	  turn	  may	  contribute	  to	  depression	  (Michael	  Maes	  et	  al.,	  2009).	  Since	  sickness	  behaviour	  was	  observed	  only	   a	   few	   hours	   after	   peripheral	   immune	   stimulation,	   however,	   it	   is	   unlikely	  that	   these	   behavioral	   changes	  were	   caused	   by	   a	   decrease	   in	   neurogenesis	   but	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could	   point	   to	   another	   possible	   mechanism	   of	   importance	   in	   depressive-­‐like	  behavior	   involving	  BDNF.	  BDNF	  has	  been	  repeatedly	  reported	   to	  play	  a	   role	   in	  depression:	   lowered	  expression	  of	  BDNF	  was	  shown	  in	  a	  post-­‐mortem	  study	  of	  depressed	  patients	   (Karege,	  Vaudan,	   Schwald,	  Perroud,	  &	  La	  Harpe,	  2005)	  and	  direct	  antidepressant	  effects	  on	  the	  behavior	  of	  experimental	  animals	  were	  seen	  after	   injection	   of	   BDNF	   into	   the	   hippocampus	   (Shirayama,	   A.	   C.-­‐H.	   Chen,	  Nakagawa,	   Russell,	   &	   Ronald	   S	   Duman,	   2002).	   Antidepressant	   treatment	   has	  been	   shown	   to	   induce	   elevated	   levels	   of	   BDNF	   in	   hippocampus	   (Nibuya,	  Morinobu,	   &	   R	   S	   Duman,	   1995).	   Furthermore,	   it	   was	   shown	   that	   chronic	  electroconvulsive	   seizures	   (ECS),	   an	   animal	   model	   of	   the	   antidepressant	  treatment	   electroconvulsive	   therapy	   (ECT),	   cause	   changes	   in	   the	   epigenetic	  regulation	  of	  gene	  expression	  of	  BDNF.	  Chronic	  ECS	  lead	  to	  alterations	  in	  histone	  modifications	  within	  the	  promoters	  for	  the	  BDNF	  gene,	  which	  in	  turn	  lead	  to	  an	  increased	   expression	   of	   BDNF	   in	   rat	   hippocampi	   (Tsankova	   et	   al.,	   2006;	  Tsankova,	   A.	   Kumar,	   &	   Nestler,	   2004).	   However,	   no	   elevation	   of	   hippocampal	  BDNF	   levels	   but	   antidepressant	   effect	   in	   female	   rats	   has	   also	   been	   shown,	  challenging	  the	  role	  of	  BDNF	  in	  depression	  (Hansson,	  Rimondini,	  Heilig,	  Mathé,	  &	  Sommer,	   2011).	   This	   points	   to	   a	   perhaps	   diverse	   role	   of	   BDNF	   in	   acute	   and	  chronic	  inflammation-­‐mediated	  depression.	  Our	  data	  suggests	  that	  a	  reduction	  in	  BDNF	   transcription	   may	   not	   only	   underlie	   the	   detrimental	   effect	   of	   immune	  activation	  on	  memory	  (Yirmiya	  &	  Goshen,	  2010)	  but	  also	  on	  mood.	  	  	  LPS	  treatment	  was	  followed	  by	  significantly	  elevated	  levels	  of	  iNOS	  mRNA	  in	  all	  observed	  brain	  regions.	  All	  LPS	  treated	  animals	  showed	  iNOS	  expression	  above	  detection	   limit	   whereas	   the	   saline-­‐treated	   controls	   often	   displayed	   expression	  below,	  leading	  to	  the	  assumption	  that	  LPS	  caused	  a	  strong	  up-­‐regulation	  of	  iNOS	  expression	  in	  the	  brain.	  This	  leads	  to	  elevated	  levels	  of	  nitric	  oxide	  (NO),	  which	  is	  toxic	  for	  e.g.	  astrocytes	  and	  other	  cells.	  A	  role	  of	  NO	  in	  the	  regulation	  of	  various	  behavioural,	   cognitive,	   and	   emotional	   processes	   has	   been	   suggested,	   and	  furthermore	   elevated	   levels	   of	   NO	   as	   a	   major	   contributor	   to	   structural	   and	  functional	  changes	   in	  the	  brain,	  which	  might	  contribute	  to	  the	  pathophysiology	  of	  depression	  (Michael	  Maes	  et	  al.,	  2009;	  Wegener	  et	  al.,	  2010).	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NFκB	  mRNA	  levels	  were	  not	  affected	  by	  LPS	  treatment	  at	  all.	  These	  observations	  go	   in	   line	  with	  previous	  findings	   in	  our	  group	  (P.	  Suchankova,	  data	  not	  shown)	  where	   no	   effect	   of	   LPS	   treatment	  was	   seen	   on	   NFκB	  mRNA	   expression	   in	   the	  brains	   of	   Flinders	   Sensitive	   Line	   (FSL)	   rats,	   an	   animal	   model	   of	   depression	  (Overstreet,	  Friedman,	  Mathé,	  &	  Yadid,	  2005)	  or	  their	  controls,	  Flinders	  resistant	  line	  (FRL)	  rats.	  Since	  activation	  of	  NFκB	  on	  a	  post-­‐transcriptional	  level	  is	  known	  to	   follow	   stimulation	   of	   TLR-­‐mediated	   pathways	   (Schmitz,	   Mattioli,	   Buss,	   &	  Michael	  Kracht,	  2004),	  our	  findings	  suggest	  that	  the	  significant	  increase	  in	  	  NFκB	  activity	   is	   mainly	   mediated	   by	   degradation	   of	   its	   inhibitor	   and	   not	   by	   up-­‐regulation	  of	  its	  transcription.	  	  
Central	  mRNA	  levels	  after	  exposure	  to	  the	  FST	  	  IL-­‐1β	  and	  TNFα	  mRNA	  in	  the	  CNS	  were	  not	  overall	  affected	  by	  exposure	  to	  the	  FST,	   suggesting	   that	   the	   FST	   as	   a	   behavioral	   test	   itself	   does	   not	   alter	   central	  expression	  of	  these	  cytokines.	  A	  down-­‐regulation	  of	  IL-­‐1β	  mRNA	  was	  seen	  in	  the	  hippocampus	  and	  TNFα	  mRNA	  levels	  were	  up-­‐regulated	  in	  the	  prefrontal	  cortex.	  Exclusion	   of	   the	   FST	   from	   the	   class	   of	   stressors	   that	   increase	   central	   IL-­‐1β	  production,	  and	  that	  behavioral	  consequences	  of	  FST	  exposure	  are	  not	  mediated	  by	  IL-­‐1β	  has	  previously	  been	  suggested,	  since	  no	  observable	  effect	  of	  the	  forced	  swim	  on	  central	  or	  peripheral	   IL-­‐1β	  protein	   levels	  was	  seen	  (Terrence	  Deak	  et	  al.,	  2003).	  	  	  It	  should	  be	  mentioned,	  however,	  that	  exposure	  to	  the	  FST	  might	  have	  induced	  an	  up-­‐regulation	  of	   IL-­‐1β,	  but	   that	   it	  was	   inhibited	  by	  glucocorticoids.	  Elevated	  plasma	  cortisol	  levels	  immediately	  after	  exposure	  to	  the	  FST	  have	  been	  observed	  (Terrence	  Deak	  et	  al.,	  2003),	  and	  adrenal	  corticosterones	  have	  been	  reported	  to	  be	   modulators	   of	   stress-­‐induced	   cytokine	   production	   and	   to	   suppress	   IL-­‐1β	  production	  both	  in	  the	  brain	  and	  in	  the	  periphery.	  However,	  this	  was	  shown	  in	  adrenalectomized	  rats	  after	  exposure	  to	  the	  stressor	  inescapable	  tail	  shock	  (K.T.	  Nguyen	  et	  al.,	  1998)	  and	  the	  effect	  of	  glucocorticoids	  during	  the	  FST	  needs	  to	  be	  investigated.	  Furthermore,	  similar	  finding	  were	  shown	  in	  adrenal	  intact	  animals	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after	   foot	  shock	  (K	  T	  Nguyen	  et	  al.,	  2000),	   showing	   that	  even	   though	   IL-­‐1β	  up-­‐regulation	   seems	   to	   be	  much	   stronger	   if	   not	   affected	   by	   cortisol,	   central	   IL-­‐1β	  responses	   to	   stress	   have	   been	   seen	   in	   animals	   with	   normally	   functioning	  glucocorticoid	   responses	   to	   stress.	   However,	   cortisol	   levels	   following	   the	   FST	  and	   its	   effects	   on	   cytokine	   expression	   should	   be	   investigated	   in	   future	  experiments.	   Stress-­‐induced	   up-­‐regulation	   of	   TNFα	   but	   not	   IL-­‐1β	   in	   the	   rat	  prefrontal	   cortex	   was	   reported	   after	   exposure	   to	   chronic	   variant	   stress	   (de	  Pablos	  et	  al.,	  2006).	  The	  prefrontal	  cortex,	  as	  well	  as	  hippocampus	  and	  amygdala,	  have	   been	   referred	   to	   as	   being	   especially	   vulnerable	   to	   the	   effects	   of	   stress	  (Andrade	  &	  Rao,	  2010),	  which	  agrees	  with	  our	  finding	  that	  most	  of	  the	  effects	  of	  the	  FST	  on	  mRNA	  levels	  were	  seen	  in	  the	  prefrontal	  cortex.	  	  No	  effects	  whatsoever	  of	  the	  FST	  on	  the	  mRNA	  levels	  of	  MMP-­‐9	  or	  TIMP-­‐1	  were	  seen	  in	  any	  of	  the	  observed	  brain	  regions,	  suggesting	  that	  the	  expression	  of	  the	  matrix-­‐metalloproteinase	   and	   its	   endogenous	   inhibitor	   is	   not	   affected	   by	   the	  procedure.	  	  	  In	   contrary	   to	   the	   LPS	   induced	   down-­‐regulation	   of	   BDNF	   in	   amygdala,	  hippocampus	   and	   the	   prefrontal	   cortex,	   exposure	   to	   the	   FST	   caused	   an	   up-­‐regulation	  of	   the	  neurotrophin	   in	  amygdala	  and	   the	  prefrontal	  cortex.	  A	  strong	  up-­‐regulation	   of	   BDNF	   after	   LPS	   treatment	   in	   combination	   with	   stress	   in	   the	  prefrontal	   cortex	  of	   rats	  has	  been	   reported	  previously	   (de	  Pablos	  et	   al.,	   2006),	  and	   an	   up-­‐regulation	   of	   BDNF	   in	   hippocampus	   and	   the	   prefrontal	   cortex	   has	  been	   correlated	   with	   a	   decrease	   in	   depressive-­‐like	   behaviour	   during	   the	   FST	  (Huang	  et	  al.,	  2011).	  	  NFκB	  expression	  seems	  to	  be	  unaffected	  both	  by	  LPS	  treatment	  and	  by	  exposure	  to	   the	   FST,	   apart	   from	   a	   slight	   up-­‐regulation	   of	   NFκB	   mRNA	   levels	   in	   the	  prefrontal	   cortex.	   This	   contradicts	   the	   possible	   explanation	   that	   the	   stressor	  forced	   swim	   induces	   NFκB	   expression	   and	   could	   thereby	   overshadow	   LPS	  induced	   NFκB	   up-­‐regulation.	   However,	   	   as	   mentioned	   above,	   NFκB	   protein	   is	  usually	  present	  in	  cells	  in	  an	  inactive	  state	  and	  requires	  proteasome-­‐dependent	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degradation	   of	   inhibitory	   proteins	   for	   its	   activation,	   thus,	   is	   mainly	   regulated	  after	  transcription	  and	  translation.	  (Schmitz	  et	  al.,	  2004)	  	  
Changes	  in	  behaviour	  during	  the	  FST	  after	  LPS	  treatment	  	  Peripheral	  immune	  stimulation	  by	  LPS	  significantly	  changed	  the	  behaviour	  during	  the	  FST,	  causing	  depressive-­‐like	  behaviour	  expressed	  as	  an	  increase	  in	  immobility	  and	  a	  decrease	  in	  swimming.	  The	  duration	  of	  climbing	  behaviour	  was	  not	  affected	  by	  LPS	  treatment.	  This	  well	  documented	  effect	  (A.	  J.	  Dunn,	  Swiergiel,	  &	  de	  Beaurepaire,	  2005;	  A.	  Dunn	  &	  Schwiergel,	  2005;	  Fu	  et	  al.,	  2010;	  Zhu	  et	  al.,	  2010)	  was	  expected,	  even	  though	  some	  sources	  report	  no	  effect	  of	  LPS	  administration	  on	  immobility	  duration	  during	  the	  FST	  (Terrence	  Deak	  et	  al.,	  2005).	  
	  
Correlation	  between	  behaviour	  and	  cytokine	  expression	  
 Immobility	  during	  the	  FST	  and	  cytokine	  mRNA	  levels	  in	  all	  investigated	  brain	  regions	  correlated	  strongly,	  suggesting	  that	  the	  levels	  of	  IL-­‐1β	  and	  TNFα	  in	  the	  central	  nervous	  system	  may	  play	  a	  role	  in	  depressive-­‐like	  behaviour.	  	  	  Although	  LPS	  strongly	  up-­‐regulated	  both	  IL-­‐1β	  and	  TNFα	  protein	  levels	  in	  serum,	  no	  significant	  correlation	  was	  seen	  between	  behaviour	  during	  the	  FST	  and	  serum	  levels	  of	  TNFα.	  IL-­‐1β	  serum	  levels	  showed	  positive	  correlations	  with	  immobility	  scores	  and	  negative	  correlations	  with	  swimming	  scores	  of	  the	  FST,	  but	  the	  significance	  level	  of	  these	  correlations	  were	  way	  below	  the	  correlations	  of	  mRNA	  levels	  in	  the	  CNS	  and	  behaviour	  during	  the	  forced	  swim,	  leading	  to	  the	  assumption	  that	  the	  central	  rather	  than	  the	  peripheral	  up-­‐regulation	  of	  these	  cytokines	  may	  be	  related	  to	  the	  behavioral	  changes.	  	  An	  up-­‐regulation	  of	  mRNA	  levels	  of	  both	  the	  inhibitory	  serotonin	  receptor	  HTR-­‐1b	  and	  the	  excitatory	  	  HTR-­‐2a	  were	  seen	  in	  the	  prefrontal	  cortex	  and,	  only	  for	  HTR-­‐2a,	  in	  striatum,	  which	  showed	  significant	  correlations	  with	  immobility	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scores	  during	  the	  FST	  (App.1,	  2).	  Since	  these	  receptors	  affect	  the	  intracellular	  expression	  of	  the	  secondary	  messengers	  cyclic	  adenosine	  monophosphate	  (cAMP),	  inositol	  triphosphate	  (IP3)	  and	  diacylglycerol	  (DAG)	  (Pytliak	  et	  al.,	  2011),	  downstream	  mechanisms	  changing	  the	  gene	  expression	  pattern	  of	  the	  affected	  cells	  can	  be	  expected.	  	  
Limitations,	  conclusion	  and	  future	  aspects	  	  Due	   to	   the	  short	   time	   interval	  between	  LPS	   injection	  and	   the	  FST	   it	   is	  possible	  that	  the	  increase	  in	  immobility	  and	  reduction	  in	  swimming	  behaviour	  during	  the	  FST	   can	   be	   classified	   as	   sickness-­‐behaviour	   rather	   than	   depressive-­‐like	  behaviour.	  In	  order	  to	  distinguish	  better	  between	  these,	  we	  could	  have	  assessed	  depressive-­‐like	   behaviour	   24h	   after	   LPS	   administration,	   when	   sickness-­‐behaviour	  was	   reported	   to	   have	   abolished	   (Bay-­‐Richter,	   Janelidze,	   Hallberg,	   &	  Brundin,	  2011).	  Since	  we	  wanted	  to	  measure	  expression	  of	  mRNA	  in	  the	  CNS	  not	  later	  than	  7	  hours	  after	  LPS	  administration,	  this	  was	  impossible.	  An	  alternative	  could	  be	  to	  assess	  locomotion	  behaviour	  of	  the	  animals	  before	  exposing	  them	  to	  the	   forced	   swim	   test	   (Bay-­‐Richter	   et	   al.,	   2011).	   This	   could	   be	   done	   in	   a	  locomotion	   box,	   which	   is	   considered	   as	   a	   relatively	   harmless	   procedure,	   not	  causing	  more	  stress	  to	  the	  animal.	  Another	  improvement	  to	  our	  study	  would	  be	  the	   testing	   of	   locomotion	   behaviour	   of	   each	   animal	   and	   subdivision	   into	   two	  equal	   groups	   before	   the	   beginning	   of	   the	   experiment,	   to	   reduce	   the	   variety	   in	  basal	  locomotor	  activity	  between	  the	  groups.	  	  Another	  future	  aspect	  to	  consider	  might	  be	  the	  possible	  influence	  of	  clock	  genes	  on	  inflammatory	  mediators	  and	  their	  role	  in	  inflammation-­‐related	  depression.	  A	  possible	   connection	  between	   the	   circadian	  clock	  and	  depression	  has	   long	  been	  postulated	   (Boivin,	   2000).	   Not	   only	   links	   between	   circadian	   rhythm	   and	  monoamine	  systems,	  but	  also	  between	  clock	  genes	  and	  cytokine	  expression	  has	  been	   reported	   (Hampp	   et	   al.,	   2008;	   Imbesi	   et	   al.,	   2009)	   and	   IL-­‐1β	   levels	   have	  been	   shown	   to	   follow	   a	   circadian	   rhythm	   (Terrence	   Deak	   et	   al.,	   2003;	   K.T.	  Nguyen	  et	  al.,	  1998).	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Microglia	   cells	   are	   activated	   to	   produce	   an	   increased	   amount	   of	   pro-­‐inflammatory	  mediators.	  Structural	  changes	  that	  lead	  to	  neurodegeneration	  are	  long	  term	  effects	  of	  the	  inflammation	  that	  is	  mediated	  by	  these	  cytokines,	  such	  as	  IL-­‐1	  and	  TNFα.	  Additionally,	  a	  down-­‐regulation	  of	  neurotrophic	   factors	  such	  as	  BDNF	  is	  seen,	  which	  leads	  to	  impaired	  neuronal	  repair	  (B.	  E.	  Leonard	  &	  Ayemu	  Myint,	   2009).	   It	   seems	   that	   pro-­‐inflammatory	  mediators	   can	   cause	   depression	  via	  several	  pathways,	  all	  of	  which	  might	  be	  valuable	  therapeutic	  targets	  in	  anti-­‐inflammatory-­‐based	   approaches	   to	   treat	   patients	   with	   depressive	   disorders	  (Loftis,	   Huckans,	   &	   Morasco,	   2010).	   Although	   inflammation	   as	   a	   therapeutic	  target	   for	   the	   treatment	  of	  MDD	  has	  been	  questioned	  due	   to	   the	   complexity	  of	  their	  interrelationship	  (Anisman,	  2009),	  too	  much	  data	  points	  to	  a	  central	  role	  of	  inflammatory	  mediators	   in	   the	   development	   and	   endurance	   of	   this	   disease	   to	  ignore	   its	   potential	   for	   improved	   treatment.	   Therefore,	   the	   mechanisms	  underlying	  this	  relation	  have	  to	  be	  investigated	  all	  the	  more	  in	  order	  to	  elucidate	  the	  pathophysiology	  of	  depression.	  To	  do	  this,	  inducers	  of	  the	  cytokine	  cascades	  and	   possible	   new	   targets	   for	   the	   treatment	   of	   mood	   disorders	   should	   be	  identified.	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Appendix	   1:	   (A)	   mRNA	   fold	   changes	   of	   serotonin	   receptor	   5-­‐HT	   R2A	   following	   i.p.	   LPS	  
injection	   and	   forced	   swim	   test	   (FST).	   Injection	   of	   LPS	   i.p.	   caused	   an	  up-­‐regulation	  of	   5-­‐HT	  
R2A	  mRNA	   in	   the	  prefrontal	  cortex	   (p=0.000)	  and	  striatum	  (p=0.000).	  No	  effect	  of	   the	  FST	  
was	   seen	   in	   any	   of	   the	   observed	   brain	   regions.	   Control	   animals	   didn´t	   undergo	   the	   FST.	  
Statistical	  significance	  relative	  to	  saline-­‐treated	  equivalents	  is	  indicated	  by	  an	  asterisk	  (***p	  
<	   0.001;	   n=6	   animals	   per	   group).	   (B)	   Correlation	   between	   immobility	   scores	  measured	   as	  
number	  of	  5	  second	  intervals	  in	  the	  FST	  and	  mRNA	  levels	  of	  5-­‐HT	  R2A.	  The	  up-­‐regulation	  of	  
5-­‐HT	   R2A	   mRNA	   following	   LPS	   treatment	   correlates	   significantly	   in	   the	   prefrontal	   cortex	  
(R=0.803,	  p=0.002)	  and	  striatum	  (R=0.743,	  p=0.006).	  mRNA	  expression	  is	  shown	  as	  negative	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Appendix	  2:	  (A)	  mRNA	  fold	  changes	  of	  5-­‐HT	  R1B	  following	  i.p.	  LPS	  injection	  and	  forced	  swim	  
test	   (FST).	   Up-­‐regulation	   of	   5-­‐HT	   R1B	   mRNA	   was	   only	   seen	   in	   the	   prefrontal	   cortex	  
(p=0.015).	   No	   effect	   of	   the	   FST	   was	   seen	   in	   any	   of	   the	   observed	   brain	   regions.	   Control	  
animals	  didn´t	  undergo	  the	  FST.	  Statistical	  significance	  relative	  to	  saline-­‐treated	  equivalents	  
is	   indicated	   by	   an	   asterisk	   (*p	   <	   0.05;	   n=6	   animals	   per	   group).	   (B)	   Correlation	   between	  
immobility	  scores	  measured	  as	  number	  of	  5	  second	  intervals	  in	  the	  FST	  and	  mRNA	  levels	  of	  
5-­‐HT	  R1B.	  LPS	   induced	  up-­‐regulation	  of	  5-­‐HT	  R1B	  mRNA	  in	  the	  prefrontal	  cortex	  correlates	  
significantly	   with	   increased	   immobility	   (R=0.686,	   p=0.014).	   mRNA	   expression	   is	   shown	   as	  
negative	  values	  of	  mean	  cycle	  threshold	  (dCt).	  
	  	   	  
Prefrontal Cortex






















































































Abstract	  	  Accumulating	  evidence	  suggests	  a	  role	  of	  inflammation	  in	  the	  pathophysiology	  of	  depression.	  However,	  despite	  the	  extensive	  research	  in	  this	  field,	  little	  is	  known	  about	  the	  underlying	  mechanisms.	  Animal	  experiments	  prove	  to	  be	  of	  great	  help,	  showing	  that	  peripheral	  inflammation	  induces	  central	  up-­‐regulation	  of	  pro-­‐inflammatory	  mediators	  and,	  at	  the	  same	  time,	  depressive-­‐like	  behaviour.	  In	  this	  study,	  the	  effect	  of	  peripheral	  administration	  of	  the	  exotoxin	  lipopolysaccharide	  (LPS)	  on	  gene	  expression	  in	  the	  brain	  areas	  amygdala,	  hippocampus,	  hypothalamus,	  prefrontal	  cortex	  and	  striatum,	  as	  well	  as	  protein	  levels	  in	  the	  serum	  of	  Sprague	  Dawley	  rats,	  was	  investigated.	  Furthermore,	  changes	  in	  behaviour	  were	  measured	  in	  the	  forced	  swim	  test	  (FST),	  an	  animal	  model	  to	  test	  for	  depressive-­‐like	  behaviour.	  The	  animals	  were	  injected	  intraperitoneal	  (i.p.)	  with	  LPS	  and	  6	  hours	  later	  tested	  in	  the	  FST.	  One	  hour	  later,	  the	  animals	  were	  sacrificed	  and	  their	  brains	  removed	  and	  dissected.	  To	  evaluate	  whether	  the	  FST	  itself	  changes	  gene	  expression	  in	  the	  brain,	  control	  animals	  that	  were	  not	  exposed	  to	  the	  FST	  were	  included	  in	  the	  study.	  mRNA	  was	  extracted	  from	  the	  different	  brain	  areas	  and	  differences	  in	  expression	  levels	  assessed	  using	  quantitative	  real-­‐time	  polymerase	  chain	  reaction	  (qRT-­‐PCR).	  LPS	  treatment	  was	  followed	  by	  an	  up-­‐regulation	  in	  gene	  expression	  of	  the	  cytokines	  IL-­‐1β	  and	  TNFα,	  and	  the	  tissue	  remodelers	  MMP-­‐9	  and	  its	  inhibitor,	  TIMP-­‐1,	  which	  correlated	  significantly	  (p=0.001	  in	  hypothalamus	  for	  both	  IL-­‐1β	  and	  TNFα)	  with	  the	  observed	  significant	  increase	  in	  depressive-­‐like	  behaviour.	  Exposure	  to	  the	  FST	  itself	  didn´t	  seem	  to	  have	  noteworthy	  influences	  on	  gene-­‐expression,	  making	  this	  test	  a	  valuable	  method	  to	  investigate	  inflammation-­‐related	  players	  in	  depression	  and	  maybe	  identify	  new	  targets	  for	  the	  treatment	  of	  mood	  disorders.	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Zusammenfassung	  	  Entzündungsreaktionen	  werden	  in	  der	  Pathophysiologie	  von	  Depressionen	  eine	  immer	  größere	  Rolle	  zugeschrieben,	  doch	  trotz	  der	  zunehmenden	  Forschung	  in	  diesem	  Gebiet	  sind	  die	  zugrunde	  liegenden	  Mechanismen	  noch	  nicht	  geklärt.	  In	  Tierversuchen	  wurde	  gezeigt,	  dass	  eine	  periphere	  Entzündung	  nicht	  nur	  die	  zentrale	  Expression	  von	  pro-­‐inflammatorischen	  Mediatoren	  erhöht,	  sondern	  auch	  zu	  Verhalten	  führt,	  dass	  dem	  depressiver	  Menschen	  ähnelt.	  	  In	  dieser	  Arbeit	  wurde	  der	  Effekt	  einer	  peripheren	  Injektion	  des	  Exotoxins	  Lipopolysaccharid	  (LPS),	  das	  auf	  der	  äußeren	  Membran	  gramnegativer	  Bakterien	  zu	  finden	  ist,	  auf	  die	  Genexpression	  in	  den	  Gehirnarealen	  Amygdala,	  Hippocampus,	  Hypothalamus,	  Prefrontaler	  Cortex	  und	  Striatum	  in	  Ratten	  untersucht.	  Außerdem	  wurden	  die	  Proteinlevels	  gewisser	  Cytokine	  im	  Serum	  der	  Ratten	  gemessen.	  Verhaltensänderungen	  nach	  der	  LPS	  Injektion	  wurde	  in	  dem	  erzwungenen	  Schwimmtest	  (engl.	  “forced	  swim	  test”,	  FST)	  erfasst.	  Dieser	  Test	  misst	  depressiv-­‐ähnliches	  Verhalten	  (engl.	  “depressive-­‐like	  behaviour”)	  in	  Tieren.	  	  	  LPS	  wurde	  den	  Tieren	  intraperitoneal	  injiziert	  und	  6	  Stunden	  später	  wurde	  ihr	  Verhalten	  im	  FST	  gemessen.	  Eine	  Stunde	  danach	  wurden	  die	  Ratten	  getötet	  und	  ihre	  Gehirne	  seziert.	  Um	  festzustellen,	  ob	  der	  FST	  an	  sich	  die	  Genexpression	  im	  Gehirn	  verändert,	  wurden	  Kontrolltiere,	  die	  nicht	  dem	  Schwimmtest	  ausgesetzt	  wurden,	  in	  die	  Studie	  inkludiert.	  mRNA	  wurde	  aus	  den	  verschiedenen	  Hirnarealen	  extrahiert	  und	  Veränderungen	  in	  der	  Genexpression	  durch	  quantitative	  Echt-­‐Zeit	  Polymerasenkettenreaktion	  (qRT	  PCR)	  gemessen.	  	  Die	  periphere	  Injektion	  von	  LPS	  löste	  eine	  erhöhte	  Genexpression	  der	  Cytokine	  IL-­‐1β	  und	  TNFα	  und	  der	  Gewebsprotease	  MMP-­‐9	  und	  deren	  Inhibitor	  TIMP-­‐1	  aus.	  Diese	  Ergebnisse	  stehen	  in	  signifikanter	  Korrelation	  mit	  dem	  Anstieg	  an	  immobilem	  Verhalten	  während	  des	  FST	  (p=0.001	  im	  Hypothalamus	  für	  IL-­‐1β	  and	  TNFα).	  Es	  wurde	  kein	  nennenswerter	  Effekt	  des	  erzwungenen	  Schwimmtests	  auf	  die	  zentrale	  Genexpression	  festgestellt,	  was	  darauf	  schließen	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lässt,	  dass	  dieser	  Test	  geeignet	  ist,	  um	  die	  zugrunde	  liegenden	  Mechanismen	  und	  die	  entscheidenden	  Mediatoren	  im	  Zusammenspiel	  von	  Entzündungsreaktionen	  und	  Depressionen	  zu	  untersuchen	  und	  vielleicht	  sogar	  neue	  therapeutische	  Ziele	  in	  der	  Behandlung	  von	  affektiven	  Störungen	  zu	  identifizieren.	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